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Abstract
In order to realise the potential of embryonic stem (ES) cells as a re-
generative medicine, it is crucial that economical, robust and scalable
bioprocesses be established. Because bioprocesses irrevocably define the
safety and efficacy of any biologically derived product, an understanding
of the the impact of the engineering environment on ES cells is sought.
This thesis uses murine ES cells as a mimic for ES cell types that will
be used in cell based regenerative medicine applications to examine the
bioprocessing impact of centrifugal recovery cells. A micro scale-down
approach was used to examine the effects of centrifugal force, centrifu-
gation time and process temperature on both the yield and biological
characteristics of cells subjected to batch centrifugation. When sub-
jected to centrifugation, mES cell loss and cell damage does not appear
to occur during the settling or cell pelleting. In general, 5—25% of cells
are lost during pellet resuspension to recover the centrifuge cells. The
level of cell loss is determined by a combination of centrifugal force, cen-
trifugation time and process temperature. The extent of damage of the
remaining cells (i.e. cells not lost during resuspension) is minimised at
lower processing temperatures. It is hypothesised that at low processing
temperatures, cell loss is minimised due to weak cell-to-cell contact and
are thus less susceptible to damage caused by the shear environment
generated to disperse the collected cell pellet.
The concept of Windows of operations was also applied to evaluate an
optimal set of centrifuge operating conditions that results in minimal
cell loss and cell damage. The process visualisation tool indicates that
operating the centrifuge at 5–9 mins × 300–500 g will result in maxi-
mum cell recovery at 4, 21 and 37oC process temperatures. The influence
of centrifugation on the biological characteristics of mES cells revealed
changes in proliferative capacity, pluripotency and differentiation status
when exposed to varying levels of centrifugal force. mES cells exposed
to increasing levels of centrifugal force up to 2,000 g progressively lost
pluripotency. The pluripotency potential of cells exposed to 3,000 g of
centrifugal force was not significantly different from un-centrifuged mES
cells. Differentiating mES cells exposed to increasing levels of centrifugal
force exhibited increased cell proliferation and a possibility of early in-
duction of endoderm and mesoderm differentiation. Although limited in
some areas, the results strongly suggest that restricting exposure to no
more than low levels of centrifugal force is necessary to safeguard the sta-
bility of the desired mES cell characteristics. Overall, the insight gained
from the work accomplished serves to create and establish an awareness
of the challenges faced within the arena of whole cell bioprocessing for
regenerative medicines.
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Chapter 1
Regenerative Medicine
Bioprocessing
1
1.1 Introduction
1.1 Introduction
The diffusion of regenerative medicine as a field of study and product technology
has gained momentum in recent years, and is at the vanguard of modern human
healthcare. Its burgeoning status is driven by the clinical desire for new therapies
and a continual further understanding of cell biology as the field progresses. This
thesis will highlight the requirement to develop robust and scalable bioprocesses to
facilitate the translation and proliferation of (cell-based) regenerative medicines as
the field ventures from a research based activity into the domain of human health-
care. The focus of this thesis is to investigate the impact of bioprocessing on cells,
in particular the centrifugal recovery of embryonic stem cells. This thesis will con-
clude with a discussion of the work accomplished and suggest new and exciting
opportunities for regenerative medicine bioprocessing research.
1.2 Regenerative medicine
Regenerative medicine is an emerging multidisciplinary field of study within biotech-
nology which has the capacity to create a new paradigm in healthcare, especially
where chronic and degenerative diseases are concerned. Regenerative medicines seek
to eliminate the debilitating effects of trauma, diseases or degeneration by restor-
ing lost native function and structure. In contrast, molecular medicines such as
analgesics, antibiotics and antibodies treating arthritis and cancer ameliorate and
manage symptoms of the condition over multiple doses, and cannot in general re-
generate tissue (Mason & Dunnill, 2008b). The crucial distinguishing features of a
regenerative medicine are: (1) the absence of fibrosis and scarring at the repair site
(Yannas, 2001); (2) regeneration is anatomical consistent and are capable of remod-
eling (Yannas, 2004); and (3) normal tissue function is established or restored.
Before the published editorial by Mason & Dunnill (2008a) providing a brief
description of regenerative medicine, there were many differing interpretations of
2
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what it should be (Daar & Greenwood, 2007). This confusion and lack of consensus
is due to the multidisciplinary nature of regenerative medicine and is not helpful.
In order to facilitate understanding and advocacy across all levels of comprehension
and interest, a clear and unified definition of regenerative medicine encompassing
the differing opinions has to be established (Mason & Dunnill, 2008a). The following
definition of a regenerative medicine is based on the aforementioned distinguishing
features of regenerative medicine. Therapies promoting regenerative medicine can
principally be differentiated into four mutually exclusive, collectively exhaustive
strategic areas. These areas are underpinned by the presence and absence of two
related determinants: cells and scaffolds (Fig. 1.1). Each strategic area is briefly
outlined in the following four sub-sections: (1) molecular medicines; (2) biomaterials
engineering; (3) cell therapy; and (4) tissue engineering.
3
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Figure 1.1: The regenerative medicine matrix. Four mutually exclusive strategic
approaches to clinical therapy as defined by the absence or presence of cells and
scaffolds.
4
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1.2.1 Molecular medicines
In general, molecular medicines are unable to regenerate tissue, nevertheless there
are exceptions in this category. Synthesised in multi-stepped bioprocesses and ad-
ministered exogenously, these molecules seek to trigger, mimic or control the innate
regenerative capacity of the patient to restore lost tissue function. For instance:
1. Cytokines and hormones form a dynamic network of signaling (glyco)proteins
that play vital roles in homeostasis, physiology and development. When ad-
ministered as a therapy, they stimulate tissue regeneration or mimic develop-
mental processes. Two examples within this category of therapy are given:
(1) recombinant human erythropoietin (rHuEPO) is a synthetic analogue of
the naturally occurring hormone erythropoietin (EPO) which is responsible
for regulating erythropiosis, and has successfully been used in the treatment
of hematological and ontological disorders (Ng et al., 2003); and (2) trans-
forming growth factor β3 (TGF-β3) when introduced into the periphery of a
healing adult wound mimics the fetal wound healing response, resulting in a
diminished inflammatory response and reduced scarring (Shah et al., 1992).
2. Nucleic acids when administered as a gene replacement or silencing therapy.
In gene replacement therapy, functional copies of a mutated gene are delivered
to affected cells via a vector to establish or restore normal function. For
example, visual function was improved in patients with Leber’s congential
amaurosis after exogeneous cDNA was introduced to correct gene mutations
(Bainbridge et al., 2008). RNA interference (RNAi) has the sequence-selective
specificity to silence genes in order to promote regeneration of tissue (Cheema
et al., 2007), and to inactivate disease causing gene expression, particularly
in gene related disorders that are not amendable to conventional treatments.
For example, silencing of Apolioprotein B (ApoB) expression. Elevated levels
5
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of ApoB is correlated with a high risk of coronary artery disease (Soutschek
et al., 2004; Zimmermann et al., 2006).
3. Chemical molecules that influence cell fate such as Reversine. Reversine is a
small molecule purine derivate capable of dedifferentiating lineage committed
myoblasts into progenitor cells capable of proliferating and redifferentiating
into adipocytes and osteoblasts (Chen et al., 2004). Whilst strictly not a
molecular medicine, the value of such molecules is worth mentioning as they
are crucial in the campaign to understand stem cell biology and its future as
a successful medicine (Ding & Schultz, 2004).
6
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1.2.2 Biomaterials engineering
This is a branch of material science concerned with the fabrication of biomimetic
substrates capable of supporting cell attachment and/or cell proliferation. Bio-
compatible and biodegradable scaffolds have been developed (Table 1.1) to provide
mechanical strength, and to mimic the 3-dimensional (3D) bio-physical and chem-
ical cues of natural extracellular matrix (ECM). The role of ECM is crucial as it
provides the substrate for cells to attach and it orchestrates tissue organisation and
remodeling (Aumailley & Gayraud, 1998). Scaffolds can be directly implanted into
the defect site as a histo-conductive substrate for surrounding cells to infiltrate and
proliferate (in vivo tissue engineering), or seeded with cells and cultured in a biore-
actor to form tissue for grafting (in vitro tissue engineering) (see Section 1.2.4 for
Tissue Engineering). With time the seeded scaffolds would degrade into non-toxic
components and be replaced by native ECM produced by the cells, thus supporting
tissue regeneration (Freyman et al., 2001). The structural organisation of a scaffold
is pivotal in its effectiveness as an ECM mimic and can be dissected into, macro–
(10−1–10−3 m), micro– (10−3–10−6 m), and nano– (10−6–10−9 m) scale features,
which together promote cell adhesion, proliferation and migration, tissue formation
and even cell differentiation (Engel et al., 2008; Lee et al., 2008). The macro-scale
structure relates to the overall anatomical shape of the scaffold to fit its purpose—to
match defect site configuration or bioreactor dimensions. The micro-scale structure
relates to its general topology and scaffold pore size, its distribution and intercon-
nectivity. Together the macro– and micro–scale features influence mass transport
of nutrients and wastes within the scaffold (Hollister, 2005), cell proliferation, cell
migration and tissue ingrowth (Moore et al., 2004). The nano-scale structures re-
late to substrate surface nano-features that control cell behaviour: cell adhesion; cell
locomotion; cell orientation/morphology; cell signaling; transcription activity; gene
expression and cytoskeleton reorganisation (Bursac et al., 2007; Stevens & George,
2005).
7
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Equally important are the bulk properties of the scaffold. Tensile strength,
its stiffness (i.e. Young’s modulus, E), rate of degradation and surface properties
influence its overall performance. Mechanical strength is demanded in applications
where high loadings are encountered. Structural tissue mimics such as bone must be
load-bearing during the regenerative process (Adachi et al., 2006), at the same time
should not completely shield ingrowing tissue from the mechanical stresses crucial in
directing tissue development. Material stiffness modulates the elastic environment
of the cells and phenotypic changes of cells with respect to the surrounding elasticity
have been reported (Engler et al., 2006). The rate of degradation of a scaffold is
controlled by its chemistry and its in vivo degradation mechanism (e.g. hydrolytic
or enzymic degradation). The mechanical strength of a scaffold is specified by
its degradation rate, thus it has to be carefully considered during design in order
to promote optimal tissue regeneration. As noted earlier, the nano-scale surface
features control cell behaviour, as can modifications made to the surface. The charge
density, derivatisation with protein motifs (Massia & Hubbell, 1990) are equally
crucial in modulating cell adhesion, survival, growth and proliferation (Hubbell,
1995; Jiao & Cui, 2007; Wilson et al., 2005).
8
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1.2 Regenerative medicine
1.2.3 Cell therapy
The direct application of cells to prevent, treat or attenuate illness is described as a
cell therapy. The use of cells in this manner is not novel and is well established in
bone marrow and blood transfusions in treating immunological and haematological
disorders. Potential therapeutic areas including cartilage damage, corneal repair,
nerve repair, diabetes, neurological disorders and reconstructive/asethetic surgery
(Dunnett et al., 2001; Elliott et al., 2007; Horas et al., 2003; Lima et al., 2006;
Nesic et al., 2006; Shortt et al., 2007; Weiss et al., 2007). These cells are normally
expanded in vitro prior to implantation.
The safety, efficacy and success of any cell-based regenerative medicine is contin-
gent on the judicious selection of both cell source and type, and its in vitro biopro-
cessing before being administered to the patient. In tissue engineering applications,
where cells are administered together with a scaffold, the material that constitutes
the scaffold has to be selected carefully. Cells used in regenerative medicine appli-
cations should be capable of proliferation whilst maintaining the desired phenotype
and biological function throughout bioprocessing. Cells may also be modified in
vitro prior to usage (Chen et al., 2003; Pollock et al., 2006). The sources of cells
used can be autologous, allogenic and xenogenic in origin.
1. Autologous cells. Cells are harvested from the patient, and are returned to
the same patient. Cells are either harvested from a site away from the point of
trauma, or at a time point prior to treatment. Grafted autologous cells have
the advantage of avoiding immune-mediated rejection responses, thus elimi-
nating the use of immunosupressive drugs. Its limitations on its use include:
insufficient useful or undamaged cells during harvesting, or harvested cells lack
the proliferative capacity to be therapeutically viable.
2. Allogenic cells. Cells are harvested from a donor rather than the recipient
patient. Allogenic cells have the advantage of being more readily available
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at short notice, but the recipient’s immune response may have to be attenu-
ated with immunosupressive drugs. Ideally, these drugs should help the host
become more tolerant or adapt to the foreign antigens in the allogenic cells
without any adverse side effects (Gorantla et al., 2000). However, this is not
the case in practice. These drugs reduce systemic immunity, thereby increasing
the risk of infection and cancer in the long term and do not completely elimi-
nate the risk of chronic rejection. Cells derived from the brain, eye and fetal
sources or transplanted into these areas appear to enjoy a degree of immune
privilege (Green & Ware, 1997).
3. Xenogenic cells. Cells harvested from a donor of another species. Their consid-
eration will be omitted from this discourse as their use has been unpopular in
clinical practice, and their commercial potential is outweighed by the following
risks: zoonotic infection (Boneva & Folks, 2004; van der Laan et al., 2000);
immune-mediated hyperacute rejection responses; greater risk of opportunis-
tic infection due to the use of higher doses of immunosupressive drugs; subtle
differences in metabolic functions and the ethical considerations debating the
beneficence of its use.
The type of cell used in a regenerative medicine rests upon on its clinical appli-
cation, relative abundance and its ability to be cultured in bulk in vitro. Cells may
be terminally differentiated somatic cells, adult or embryonic stem cells. Terminally
differentiated somatic cells such as fibroblast, smooth muscle cells, keratinocytes
and chondrocytes confer tissue specific characteristics and are amiable to in vitro
culture techniques as are adult stem cells. Both terminally differentiated somatic
cells and adult stem cells however have a finite replicative capacity and experience
replicative senescence (Bruder et al., 1997; Hayflick, 1979). As a result, the rate
of cell proliferation in vitro is an important determinant in selecting the type of
cell to be used in a regenerative medicine (Shieh & Vacanti, 2005). Cells such as
11
1.2 Regenerative medicine
neurons and cardiomyocytes have a low (or zero) rate of proliferation in vitro, as a
consequence are unsuitable as a therapeutic choice. An alternative strategy is thus
required to make up sufficient numbers of these cells for therapy within an appropri-
ate timeframe. A potential solution is offered in the form of embryonic stem cells,
not only to manufacture cells with a poor rate of proliferation but also for cell types
not available due to degeneration, disease or defect. Adult and embryonic stem cells
are further described in Section 1.4.
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1.2.4 Tissue engineering
Tissue engineering is a collective term describing the understanding and integration
of science from many diverse areas such as biomaterials, developmental and cell biol-
ogy, engineering sciences, surgical and clinical practice (Langer & Vacanti, 1993). It
is based on the tenet of allying a suitable biomaterial with pertinent cell types under
favorable conditions in vitro to synthesise neo-tissue. This is acheived by shaping of
a biocompatiable and biodegradable material into the desired 3D geometry to form
a scaffold that provides the appropriate bio-physical and chemical milieu for cell at-
tachment and tissue synthesis. The scaffold is seeded with cells and allowed to grow
and mature in a bioreactor nourished by tissue culture medium, eventually forming
a living functional tissue substitute ready for grafting (Atala et al., 2006; Sherwood
et al., 2002). Examples of tissue engineered bladder, blood vessels, kidney, repro-
ductive organs, skin and urethra for clinical application are given in Atala (2004)
and Metcalfe & Ferguson (2007). The building of complex 3D tissues composing of
multiple cell types and its associated small scale functional features (e.g. intestinal
villi, renal corpuscle and nephron), its vascularisation and in vitro culture are major
challenges in this area.
In situ organogenesis and tissue sythensis is a consequence of highly orchestrated
spatial and temporal cell signaling processes. These signaling processes can vary in
intensity and originate from cell-to-cell contact, cell-to-scaffold/ECM contact or ar-
rive in the form of soluble factors such as hormones and cytokines. The current
understanding of these processes is in its infancy but fast growing thus potentially
allowing the construction of complex tissues in vitro. The study on skin and pe-
ripheral nerve synthesis by Yannas (2004) may provide clues and general rules for
progress in this area.
An effective nutrient supply and distribution is another crucial factor in the
construction of large and complex tissues. Under static conditions cell growth on
scaffolds occur within 1 millimetre from the liquid-scaffold interface as the transport
13
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of oxygen, essential nutrients and cellular waste products are limited to diffusional
transport (Dunn, 2008). To overcome this limitation, there exist three vascular
based strategies to supply the required nourishment to support cell growth and
proliferation in large tissue constructs: (1) utilising the pre-existing vascular beds
of the host or graft, however this approach is only suited to thin tissue constructs
such as skin (O’Ceallaigh et al., 2007); (2) encouraging the growth of blood vessels
by using angiogeneic factors such as vascular endothelial growth factor (VEGF),
fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF) (Lokmic
& Mitchell, 2008; Soker et al., 2000); and (3) building into the scaffold a blood
distribution system. Hoganson et al. (2008) discusses the applications of pre-formed
scaffold embedded channel system for liver and lung tissue engineering.
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1.3 Bioprocessing
Since the development of recombinant DNA techniques in the 1970s, the diffusion of
modern biotechnology on the global stage has transformed agriculture, healthcare
and economic systems in many countries throughout the world. It is one of the
most enabling industrial innovations in recent times driven by scientific discovery
and technological innovation in order to satisfy a market need. It has led to the
introduction of a large number of products with many diverse applications (Giovan-
netti & Jaggi, 2007). Crucial to the manufacturing of these products is the field of
bioprocessing. Conceptually, a bioprocess is an industrial scale sequential multi-step
procedure used to synthesise, recover, isolate, purify, polish and formulate a prod-
uct that is a derivative of a biological system. A bioprocess is customarily divided
into upstream and downstream processing. All upstream and downstream unit op-
erations interact very strongly with each other and the choice of unit operation
significantly influences overall bioprocess performance (Zhou & Titchener-Hooker,
1999).
The safety and efficacy of any biological product is singly determined by its iden-
tity (Kuhlmann & Covic, 2006) and during its manufacture, the bioprocess uniquely
specifies the product. Differences in manufacturing procedures can affect the prod-
uct and ultimately the consumer (Casadevall et al., 2002). Detecting changes in
product identity attributed to changes in bioprocess is compounded by its biological
complexity. Product identity changes will go undetected if they occur beyond its un-
derstanding or analytical means (Chirino & Mire-Sluis, 2004). In order to mitigate
these risks, manage process variations and product heterogeneity, the manufacture
of biological products for healthcare applications operate within highly structured
environments governed by strict operational procedures (e.g. current good manufac-
turing practice (cGMP), total quality management (TQM)) and process controls.
The success of a bioprocess is measured by the safety and efficacy of its product
and its commercial profitability. Crucial to the success of any bioprocess is a detailed
15
1.3 Bioprocessing
qualitative understanding of the bioprocess environment at the design stage so that
any issues that arise can be addressed. This is achieved by examining the perfor-
mance of a particular unit operation and how it integrates within the entire process.
Appreciation of the variations within the many interacting variables, how they are
accumulated and their influence on the product will assist in establishing acceptable
operational ranges and set-points. A qualitative understanding of the bioprocess
environment also aids in establishing suitable manufacturing in-process monitoring
and control strategies, and identify critical process variables. Titchener-Hooker et al.
(2008) discusses a micro biochemical engineering approach to bioprocess design and
is especially useful where large quantities of material are not readily available.
1.3.1 Whole cell bioprocessing
The emerging field of whole cell bioprocessing is driven by the increasing amount
of basic science research and number of potential therapies entering clinical trials.
Whole cell bioprocessing refers to the idea that live cells are a major constituent of
the final product and are omnipresent throughout the entire bioprocess — from cell
procurement from a donor source, to its expansion and isolation in culture, storage
and when implanted into a patient (Mason & Hoare, 2007). Cells at every stage
of the bioprocess have to be maintained in a satisfactory state to ensure product
quality, safety and efficacy.
In a review by Kemp (2006), the author traces the history and success of regen-
erative medicine to date of pioneers and early adopters within the field. Whole cell
bioprocessing is an evolution of the well established bioprocess industry that has
developed successful process for products derived from the culture of cells. Whilst
sharing some sharing some fundamental conceptual bioprocess frameworks and fun-
damental engineering tenets with traditional bioprocesses, whole cell bioprocessing
has many distinguishing characteristics (Mason & Hoare, 2007). For example: the
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omnipresence of cells in the bioprocess (as mentioned above); reduced nutritional
and gas transport to cells when fabricated into neo-tissue; short shelf-life during
transportation or storage due to unique nutritional and oxygen demands; where
cells are used, the homogeneity and potency of a given population of therapeutic
cells, scalability of bioprocess, cell source contamination and process sterility issues
(Dunn, 2008; Klein et al., 2006). These unique characteristics of a whole cell bio-
process impose significant biochemical engineering challenges at various levels of
its management and execution. An editorial by Mason & Hoare (2006), the au-
thors emphasise the need to draw from experiences within and beyond the field of
biotechnology to facilitate the commercial development and exploitation of whole
cell bioprocesses. For instance, process automation to facilitate throughput and
product consistency and the adoption of management information systems (MIS),
enterprise resource planning (ERP) systems and manufacturing execution systems
(MES) to support and manage manufacturing and business decisions.
From a biochemical engineering perspective, robust and scaleable whole cell bio-
processes need to be developed in order to fulfill their market potential, and a list of
desirable whole cell bioprocess characterisitcs is provided in Mason & Hoare (2006)
1.3.2 Bioprocess conditions
One of the most crucial aspects in the development of cell based regenerative
medicines is its bioprocessing environment. As noted earlier, any biologically de-
rived product is defined by the process, this maxim takes on a greater significance
where cells are themselves the final product. The bioprocessing of cells for regener-
ative medicine exposes them to a diverse range of conditions and gradients such as
gas and nutrient concentrations, osmolarity, pH, temperature, hydrostatic pressure,
shear conditions, relative centrifugal force and interfacial gas-liquid phenomena. As
animal cells are recognised to be delicate and susceptible to physical and biochemical
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cues from its surroundings (Al-Rubeai et al., 1995; Papoutsakis, 1991), its biopro-
cessing conditions present unique challenges during manufacture. When exposed to
undesirable conditions damage to cells occur. Damage may result in loss of cells or
cell viability (see Section 3.3.1 for detailed description). More subtle to cell damage
are changes in cell physiology such as metabolism, protein synthesis, proliferation
rates, apoptotic profile, phenotype, genotype, karyotype and epigenetic profile (Al-
Rubeai & Singh, 1998; Lin et al., 2005; Seow et al., 2001). The effects of cell damage
influence overall bioprocess productivity and product safety and efficacy. As a con-
sequence it is crucial to take into consideration the likely sources of damage and
curb unwanted cell damage by minimising its exposure to such influences.
1.3.2.1 Temperature
Temperature is one of the many key factors that determine cell survival. When
exposed to temperatures above physiological, animal cells are rendered non-viable
(Westra & Dewey, 1971) mainly due to the denaturation of cytoplasmic proteins
which are essential in maintaining normal cellular function. However, when exposed
to sub-physiological temperatures above freezing, animal cells have been shown to
adapt to these changes in a variety of ways. Cells are known to be able to recover
from hypothermic conditions without suffering long term consequence and this has
been exploited in the transport of organs and cells in transplant medicine. Cells
lines have also been induced to become cold-tolerant (Glofcheski et al., 1993; Rus-
sotti et al., 1996). Three levels of sub-physiological temperatures can be specified:
moderate (33–25◦C), mild (20–16◦C) and severe (10–4◦C) hypothermia, and its ef-
fect on cultured cells is described in detail in Hunt et al. (2005). Briefly, hypothermic
exposure has been shown to disrupt cell cytoskeleton, suppress protein synthesis and
modify cellular membanes (Fujita, 1999; Waugh, 1982). Depending on severity of
exposure (e.g. time and temperature) and cell type, apotosis can be prevented or in-
duced (Perotti et al., 1990; Rauen et al., 2000; Sakurai et al., 2005). Cells rewarmed
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from hypothermic conditions to physiological have been reported to be apoptotic
(Healy et al., 2006; Rauen et al., 2000) and express heat shock proteins (Liu et al.,
1994). Heat shock proteins are a group of proteins which are expressed when cells
are exposed to elevated temperatures or subjected to environmental stress. Expos-
ing cells to hypothermic temperatures have been demonstrated as a manufacturing
strategy to increase protein of interest yields in culture (Chong et al., 2008; Fox
et al., 2004) or to help schedule the scaling up of manufacturing seed trains (Hunt
et al., 2005).
Under bioprocess conditions exposure to freezing temperatures is lethal to un-
protected cells. During cryopreservation of cells for long term storage, measures are
taken to avoid cell damage (via solute concentration, dehydration and intra-/extra-
cellular ice formation) by controlling the velocity of cooling in the presence of a
cryopreservant (e.g dimethyl sulfoxide (DMSO) or glycerol) (Gao & Critser, 2000;
Mazur, 1970)
1.3.2.2 Hydrodynamic environment
The hydrodynamic forces found within a bioprocess can trigger a variety of stress
responses in animal cells including cell necrosis and cell loss (Zoro et al., 2008). These
forces occur in every aspect of a cell based regenerative medicine bioprocess: from
cell biopsy, to its culture in vessels, primary recovery, pipe transfer and pumping, and
eventually when returned back to the patient. The term shear damage is widely used
in bioprocessing to describe the hydrodynamic forces that results in cell damage.
Although in some instances, cell damage is not entirely ascribed to shear rate or
shear force (Chisti, 2001). Cell sensitivity to shear damage has been reported in
both laminar and turbulent flow regimes and the level of cell damage incurred is
related to the mean bursting cell membrane tension and growth phase (Born et al.,
1992). Under laminar shear stresses, damage varies considerably from 0.2 × 103—
100 N m−2 with substantial damage occurring from 100—350 N m−2 (Born et al.,
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1992). It is difficult to define shear forces in turbulent flow and thus are usually
expressed as a local or average power dissipation rate (W kg−1 or m2 s−3) which is
independent of flow regime. In turbulent flow average power dissipation rates up to
2× 104 W kg−1 were presumed to interact with cells via appropriately sized eddies
that cause membrane distortions that increase membrane tension and surface energy,
and consequently cell disruption (Zhang et al., 1993). Eddie sizes approximating the
cell diameter or smaller (Kawase & Moo-Young, 1990; Kunas & Papoutsakis, 1990),
distort the membrane and when membrane bursting tension and bursting surface
energy are exceeded, cells are disrupted (Zhang et al., 1993). Eddies larger than the
cell entrain the cell without causing damage (Maa & Hsu, 1996). Cells entering a
contractile flow regime (equivalent to extensional flow (Taylor, 1934)) will experience
compression perpendicular to the direction of flow, whilst simultaneous experiencing
extension in the direction of the flow. Animal cells introduced into contractile flows
have been reported to withstand energy dissipation rates up to 104—105 W kg−1 (Ma
et al., 2002). Cell damage due to un-submerged and submerged jets are described in
Chan et al. (2006) and MacLoughlin et al. (1998). Whilst the work in either study
was not carried out with animal cells, the cell damage mechanisms are relevant and
can be applied. Bubble disengagement at the bulk liquid-gas interface has been
associated with animal cell damage in culture (Chisti, 2000). During the collapse of
a disengaging bubble, regions of high strain rates develop at the liquid-gas interface
(Garcia-Briones & Chalmers, 1994). Depending on bubble size, energy dissipation
rates of bubbles disengaging at the surface range between 1× 101—1× 107 W kg−1
with smaller bubbles generating higher energy dissipation rates (Boultonstone &
Blake, 1993).
1.3.3 Primary recovery
The separation of cells from its suspending liquor is an important criteria in spec-
ifying overall bioprocess yield in cell based bioprocesses. The conservation of cells
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during separation is crucial in regenerative medicine applications, and necessary to
avoid inordinate intracellular product loss or extracellular product contamination in
protein bioprocessing. In order to separate and concentrate cells, centrifugation and
tangential flow microfiltration are in competition. A third, the adsorption of cells in
an expanded bed exists as a proof of concept and requires considerable development
for industrial deployment (Halperin et al., 1984).
Continuous flow disc stack and multi-bowl centrifugation are the most common
forms of centrifugal cell separation in the bioprocess industry because they com-
bine low running costs with high throughput (Pilot scale: 10—100s L hr−1 and
industrial scale: > 1, 000 L hr−1) and uncomplicated process and operational de-
velopment (Hutchinson et al., 2006). Traditionally used to separate microbial cells
and protein aggregates, they are increasingly used to separate fragile animal cells
(Lander et al., 2005; Lightfoot & Moscariello, 2004). However, their high opera-
tional speeds are also associated high levels of cell disruption generating sub-cellular
particles (Kempken et al., 1995). The high shear regions encountered at the feed
zones in both centrifuge types are the cause of cell damage (Boychyn et al., 2000;
Maybury et al., 1998). Boychyn et al. (2001, 2004) modeled these feed zones with
computational fluid dynamics (CFD) to characterise the energy dissipation rates.
A maximum energy dissipation rate of 2 ×105 W kg−1 was determined for a disc
stack centrifuge operating at a flowrate of 15—80 L h−1 and at 167 rps, and 6 ×105
W kg−1 and 12 ×105 W kg−1 were determined for a multi-chamber bowl centrifuge
under flooded and partially-flooded (70%) conditions respectively. Cell damage can
also occur in centrifuges with solids discharge capability. The collected cells are
either scraped from the collection bowl or ejected violently from the bowl into an
adjoining collection chamber at speeds up to 100 m s−1 (Chan et al., 2006).
The use of tangential flow microfiltration for large-scale separation of animal cells
has been limited due to shear environment induced cell damage within the filtration
module (Maiorella et al., 1991). Performance of tangential flow microfiltration is
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gauged on filtrate flux rates across the filtration membrane, and the accumulation
of a concentration of cells and cell debris (concentration polarisation effect) coupled
with membrane fouling are the governing phenomena that limits performance of
the filtration module (Belfort et al., 1994). The most common method employed
to improve transport performance across the membrane involve adjusting fluid flow
characteristics within the filtration module. This is achieved by providing local high
shear rates or inducing Taylor or Dean Vortices (Vanreis & Zydney, 2007), to re-
duce the effects of concentration polarisation and fouling. However, in doing so,
the susceptibility of animal cells to shear damage has to be considered. Maiorella
et al. (1991) identified a critical wall shear rate (3,000 s−1) at which cell damage
will occur for a range of animal cell types. To deploy tangential flow microfiltration
as a harvesting operation for animal cells, process conditions at which cell damage
is minimal has to be established; van Reis et al. (1991) describes the scale-up devel-
opment of an animal cell tangential flow microfiltration unit capable of processing
5,000 L hour−1.
The use of centrifugation and tangential flow microfiltration is also found in
clinical apheresis, where low volumes (0.25—1 L) of precious cells are processed.
Apheresis describes any procedure in which blood is withdrawn from a donor and
separated into its constituent components to be retained or transfused into a recipi-
ent. As an emerging field with very specific needs, it is likely whole cell bioprocessing
will borrow heavily from both clinical apheresis and industrial cell separation pro-
cesses to adopt an effective primary recovery scheme.
1.3.4 Windows of operation
The concept of windows of operation was first described by Woodley & Titchener-
Hooker (1996) as a bioprocess design tool. It has been applied in various scenarios to
frame critical operating parameters in a graphical format to facilitate analysis and
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bioprocess design decisions (Blayer et al., 1996; Zhou & Titchener-Hooker, 1999).
Bioprocesses and the unit operations they are made up from, have many interacting
variables and often have to be considered simultaneously for a desired level of per-
formance (Salte et al., 2006). A window of operation is a graphical visualisation of
an optimum operating region within this multivariable parameter space as defined
by the system’s governing process constraints and correlations.
Building a windows of operation requires the identification of process and system
constraints that may either be quantitative or qualitative. Subsequently, two com-
mon variables between the relationships that govern the interdependencies between
the constraints have to be identified and established as the axes of the window (Fig.
1.2). The shape and not just the area of a plotted window of operation is indicative
of bioprocess or operational robustness. The concept of windows of operation can be
extended into a 3D parameter space by identifying three common variables amongst
the relevant constraints and is termed volumes of operation (King et al., 2004).
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Figure 1.2: Building a window of operation. Reproduced from Woodley & Titchener-
Hooker (1996).
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1.4 Stem cells
Stem cells are cells that are capable of: (1) self-renewal, (2) the plasticity to dif-
ferentiate into a range of specialised cell types, and (3) immortality–capable of un-
dergoing unlimited expansion. The capacity for self-renewal and differentiation is
underpinned by symmetrical or asymmetrical stem cell division and is the mecha-
nism used to maintain an appropriate number of required cell types (Morrison &
Kimble, 2006). Stem cells not only specify the starting material for organs and
tissues in embryogenesis, they are also responsible for their continual maintenance,
renewal and growth throughout ontogeny (Zandstra & Nagy, 2001). Because of
these unique properties, stem cells represent an unlimited and renewable source of
cells for cell therapy for regenerative medicine (Ame´en et al., 2008; Lerou & Daley,
2005; To¨gel & Westenfelder, 2007).
1.4.1 Adult stem cells
Adult stem cells (ASCs) are lineage specific cells that are found in various tissues
throughout the body and are responsible for tissue homeostasis and its regeneration
after damage. They reside in niches within tissue, and are specified by the highly
specialised niche cells that regulate their proliferation and differentiation (Sneddon &
Werb, 2007). Major adult stem cell populations have been found in niches within the
eye (Dua et al., 2005), in the gastrointestinal tract (Brittan & Wright, 2002), in skin
for hair (Oshima et al., 2001) and within the bone marrow (Dazzi et al., 2006) and are
reviewed in Moore & Lemischka (2006). In vitro, ASCs are incapable of long-term
self renewal, this is in contrast to their behavior in vivo where continual self-renewal
is essential in maintain life-long homeostasis (Mountford, 2008). This discrepancy
in behaviour is attributed to the strict regulatory controls of the stem cell niche
environment has over adult stem cell proliferation and differentiation (Trounson,
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2006). The current inability to maintain and control ASC proliferation over extended
periods of time in culture limits their potential in research and therapy.
1.4.2 Embryonic stem cells
Pluripotent embryonic stem (ES) cells are most commonly derived from the inner
cell mass (ICM) of preimplantation embryos and in vitro fertilisation (Evans &
Kaufman, 1981; Thomson et al., 1998). Alternative methods of ES cell-like cell
derivation can be found in Takahashi & Yamanaka (2006) (e.g. induced pluripotent
stem cell (iPS)) and Chen et al. (2003) (e.g. nuclear transfer ES cells (ntESC)).
ES cells are capable of long-term undifferentiated expansion in vitro (Amit et al.,
2000) and do not appear to undergo replicative senescence (Zeng & Rao, 2007),
whilst maintaining the potential to differentiate into the three primary germ layer
lineages and germline cells (Aflatoonian & Moore, 2006). The three primary germ
layers consist of the ectoderm, mesoderm and endoderm and they give rise to all
the tissue and organs during organogenesis: Ectoderm, the outer most primary
germ layer develops into the nervous system and epithelial tissue; Mesoderm, the
middle primary germ layer develops into muscle, blood and connective tissue; and,
Endoderm, the inner most primary germ layer develops into the respiratory tract
and the gut. Germline cells include the sex cells (e.g. egg and sperm) and the
gametocytes.
In situ the ICM from which ES cells are derived from rapidly differentiate leading
to the development of the embryo. As a consequence, pluripotent ES cells are an
artefact of their in vitro environment (Avery et al., 2006). Oct4, Nanog and Sox2
have been identified as key transcriptional factors in maintaining pluripotency in
both mouse and human ES cells within the self-renewal signaling cascade (Avery
et al., 2006; Wobus & Boheler, 2005).
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1.4.2.1 Mouse embryonic stem cells
The first mouse embryonic stem (mES) cell lines were derived from the ICM of
mouse blastocysts (Evans & Kaufman, 1981) and cultured on mitotically inacti-
vated embryonic fibroblast cells (MEF or feeder layers) in order to maintain mES
cell pluripotency in vitro. These cells can be expanded indefinitely in vitro to give
relatively homogenous and undifferentiated mES cell populations (Smith, 2001). Be-
cause mES cell pluripotency could only be maintained when cocultured with MEFs,
it was reasoned that some extrinsic factor exist to either suppress differentiation or
promote self-renewal. This factor was identified to be leukemia inhibitory factor
(LIF) (Williams et al., 1988), and the LIF\STAT3 signaling pathway has been es-
tablished to play a central role in maintaining mES cells pluripotency (Boeuf et al.,
1997). Addition of LIF to non-serum free culture medium enables feeder free culture
of mES cells. When mES cells are introduced into embryos and implanted, they give
rise to chimeras exclusively descended from ES cells (Nagy et al., 1993; Wang et al.,
1997).
More recently, pluripotent stem cells derived from the epiblast layer (epiblast
stem cell or EpiSC) of post-implantation mouse embryos has been established (Brons
et al., 2007). Although EpiSC cells display the key features of a stem cell (e.g.
self-renewal, plasticity and immortality), they are distinct from mES cells in their
epigenetic state and signals that control their differentiation, and share key defining
features with human ES cells (Tesar et al., 2007).
1.4.2.2 Human embryonic stem cells
The techniques used to derived mES cells proved critical in establishing human
ES (hES) cells from pre-implantation embryos. Like mES cells, hES cells can be
maintained in a pluripotent state when cocultured on feeder layers. In contrast,
unlike mES cells, LIF is unable to maintain hES cells in a pluripotent state when
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cultured in feeder free conditions. The precise action of MEF layers in maintaining
plurpotency in hES cells has yet to be elucidated, however some hES cell lines have
been successfully cultured in animal free conditions (Lu et al., 2006), ECM derived
preparations (Ludwig et al., 2006) or conditioned medium supplemented with bFGF.
The activin A\TGFβ signaling pathway is essential for hES cell self-renewal (Beattie
et al., 2005).
1.4.2.3 Induced pluripotent stem cells
Induced pluripotent stem (iPS) cells are pluripotent cells that that have been derived
from reprogramming somatic cells with introduced ectopic transcription factors. In
mouse fibroblast iPS cells, these factors have been identified to be Oct4, Sox2, c-
Myc and Klf4 (Takahashi & Yamanaka, 2006), and in human fibroblast iPS cells
these factors are OCT4, SOX2, NANOG and LIN28 (Takahashi et al., 2007). iPS
cells have also been recently derived from hepatocytes (Aoi et al., 2008), mature
B lymphocytes Hanna et al. (2008) and pancreatic β cells (Stadtfeld et al., 2008).
iPS cells exhibit the morphology and growth properties of ES cells and express ES
cell marker genes (Takahashi & Yamanaka, 2006). Although the derivation of iPS
cells from somatic cells circumvents the controversial use of embryos, the derivation
efficiency is low when compared to hES cell derivation protocols (<0.1 % vs. ∼ 20
%).
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1.5 Investigational objectives
Although ES cells represent an unlimited source of of cells for cell based regen-
erative medicines, they are themselves not the therapy. Grafting pluripotent ES
cells directly into a host risks the formation of teratomas –tumor like cell masses
containing cells belonging to all three primary germ layers– and immune rejection
responses. The ability of ES cells to form teratomas in vivo is a defining character-
istic of pluripotent ES cells. The therapeutic cells are differentiated derivatives of
the original population of ES cells and can exist either as terminally differentiated
somatic cells or as lineage committed precursor cells.
Within any bioprocess that exploits the properties of ES cells for therapy, a
distinction between the source of ES cells and its subsequent differentiation can be
made to facilitate operations. Where ES cells are grown to required numbers whilst
still maintaining their pluripotent properties, these operations may be classified as
expansion operations. Expansion operations provide the necessary starting material
for differentiation operations where ES cells are directed towards the required cell
phenotype. This distinction between the different operations are exemplified in
Figure 1.3. With expansion or differentiation operations, there exist a variety of
unit operations and handling procedures to achieve a specific bioprocess target. It
is likely that centrifugation will be employed to facilitate ES cell expansion and
differentiation procedures.
This thesis examines the impact of centrifugal recovery of mES cells and cen-
tres about the use of a laboratory scale bench top centrifuge fitted with swing-out
rotors. mES cells were selected as a mimic for ES cell types that will be used cell
based regenerative medicines. The overall objective of this thesis is to carry out
fundamental underpinning work on centrifugation within a regenerative medicine
bioprocessing framework to enable its application in the production of cell based
therapies. Current literature relating to centrifugation performance during recovery
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of cells relate to shear damage predictions using computational fluid dynamics, scal-
ing issues or operational efficiency issues to separate cells from the liquor for protein
recovery. There is a distinct absence of literature related to ES cell centrifugation
and how centrifugation conditions might affect ES cell properties; this is largely due
to the lack of developments in this areas. The work accomplished potentially reveals
important bioprocess design implications specific to centrifugation for regenerative
medicine processing. In this thesis, the impact of centrifugal recovery on ES cells
are segregated into two distinct areas: (1) the physical impact of centrifugation on
mES cells; and (2) the impact of centrifugation on the phenotype of mES cells.
Preliminary studies involving the centrifugation of human neonatal foreskin derived
fibroblast aided in the development of a suitable and robust experimental schema.
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1.5.1 The physical impact of centrifugation on mES cells
This study seeks to examine the impact of centrifugation of mES cells by quantifying
the level of cell damage incurred. Millilitre volumes of mES cell suspensions repre-
sentative of routine cell harvesting operations were exposed to a range of centrifugal
force (0—3000 g) and centrifugation time (0—100 mins) at 4, 21 and 37◦C process
temperature. Two key measures of cell damage, overall cell concentration and cell
viability were monitored before and after centrifugation to provide the necessary
information to characterise cell damage in relation to the bioprocessing conditions.
Windows of operation will be generated based on the cell damage data to visualise
an area of available operating conditions for centrifugation when subject to user
defined constraints. A mixture of theoretical and experimental work will be used to
deliver the proposed window of operation.
1.5.2 The impact of centrifugation on the phenotype of mES
cells
This study examines the influence of centrifugation on two defining characteristics
of stem cells; pluripotency and differentiation potential. Millilitre volumes of mES
cells were exposed to a range of centrifugal force (0—3000 g) and returned to culture.
The impact of centrifugation on mES cell pluripotency and differentiation potential
were monitored in a feeder free monolayer culture and static suspension embryoid
body (EB) culture system respectively. Changes in cell phenotype were tracked
through green fluorescent protein (GFP) and gene expression.
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2.1 Introduction
The research in this thesis centers around the use of millilitre (mL) scale experi-
ments of feeder free murine embryonic stem (mES) cells. Experimental design is to
provide a representation of actual scale processes to investigate the impact of batch
centrifugation on the cell properties.
2.2 Equipment and cell culture
This section describes the centrifuge equipment and cell culture technique used
throughout this investigation.
2.2.1 Centrifuge equipment
An Eppendorf 5810R temperature controlled laboratory bench-top centrifuge is
used, fitted with the A-4-62 rotor and swing out buckets. Cell suspensions were
centrifuged in 2 mL micro-centrifuge tubes containing a machined acrylic insert
(Fig. 2.1). The insert aids in the definition and partitioning of the sediment and the
supernatant fraction. It also aids in minimising the disturbances to the sedimented
cells during aspiration of the supernatant. Due to the presence of the insert within
the micro-centrifuge tube, its maximum working volume is reduced to 1.7 mL.
2.2.2 Cell culture
Oct4-GiP ES cells (Stem Cell Sciences plc, Edinburgh, UK) (hereafter known as
Oct4 -GFP) made on a pure 1290la background expressing resistance and cytoplas-
mic green fluorescence protein (GFP) under the direct regulator control of the mouse
Oct4 gene (Ying et al., 2002) were cultured on 0.1% (w/v) porcine gelatin (Sigma-
Aldrich, Poole, UK) coated T-flasks (Iwaki, Funabashi, Japan) and maintained in
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Glasgow Minimum Essential Medium (GMEM) (Sigma-Aldrich, Poole, UK) con-
taining: 10% (v/v) foetal bovine serum (FBS) (Invitrogen, Paisley, UK), and sup-
plemented with 0.1 m M 2-β-mercaptoethanol (BDH, Poole, UK); 1× minimum es-
sential medium with non-essential amino acids (MEM NEAA) (Invitrogen, Paisley,
UK); 1mM sodium pyruvate (Invitrogen, Paisley, UK); 2 mM L-glutamine (Invit-
rogen, Paisley, UK); and 106 units L−1 leukemia inhibitory factor (LIF) (Chemicon,
Watford, UK). All cell cultures were incubated at 37◦C, with a 7% CO2 content in
air. Sub-confluent monolayers of cells were routinely passaged at a 1 in 8–10 split ra-
tio every two days. Dissociation of cells was achieved by removing the spent media,
and washing the cells with Dulbeccos phosphate-buffered saline (DPBS) (Sigma-
Aldrich, Poole, UK), and incubating for 4 minutes with 0.025% (v/v) trypsin (In-
vitrogen, Paisley, UK), supplemented with 1% (v/v) chick serum (Sigma-Aldrich,
Poole, UK) and 0.3 mM ethylenediaminetetraacetic acid (EDTA) (BDH, Poole, UK)
in DPBS. Dissociated cells were subsequently quenched with complete media and
pelleted at 280 g × 3 min ready for passaging or resuspended in complete medium
ready for experimentation.
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Figure 2.1: Cross-sectional view of 2 mL centrifuge tube with machined acrylic
insert. The centrifuge tube has a working volume of 1.7 mL and acrylic insert
aids in the partitioning and definition of the supernatant and sediment fractions.
Proportions are drawn to scale.
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2.2.3 Cell enumeration and GFP expression measurement
Cell enumeration and GFP expression measurement was accomplished using bench
top flow cytometry. Samples were analysed using the Guava EasyCyte Plus System
(Guava Technologies, Stamford, UK) with the bundled ExpressPlus software, v3.x.
Cell enumeration was achieved using Guava Technologie’s proprietary cell counting
dye, ViaCount Flex Reagent, to determine cell numbers and cell viability. ViaCount
Flex Reagent consists of a proprietary formulation of propidium iodide (PI) and a
membrane permeable DNA stain; the differential permeability of each dye within
the cells when detected by the instrument is able to identify nucleated cells and dis-
tinguish between viable and non-viable cells. For cell enumeration, monodispersed
cell suspension samples were diluted with DPBS to within the range of the detection
rate of the instrument (10 to 500 events per µL) to give a volume of 197 µL. 3 µL
of ViaCount Flex Reagent was then mixed into the diluted cell suspension to make
up a total sample volume of 200 µL and allowed to incubate at room temperature
for 5 minutes before analysis. GFP fluorescence was measured concurrently during
enumeration on the PM3 channel of the instrument. For GFP expression analysis,
a gate was placed around the viable cell population to identify GFP-positive and
-negative populations (GFP+ and GFP− respectively). The GFP-positive popula-
tion from control samples were further gated into 50% high and 50% low expression
areas (Fig. 2.2 A). As a results of the placed gates, GFP expression for a viable cell
population can be labeled as: negative, high and low. The GFP settings from each
control sample were applied across all other samples to evaluate shifts in expression
within the GFP-positive cell populations (Fig. 2.2 B). Percentage yield of Oct4 -GFP
expression on viable cells is calculated according to the following formula:
YGFP =
CGFP
CV
× 100 (2.1)
Where YGFP is the yield of Oct4 -GFP expressing cells as a percentage (%) and CGFP
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is the concentration of cells expressing Oct4 -GFP (cells mL−1). All experimental
samples were analysed in triplicates or more, with data presented as a mean ±
2 standard error (SE). Statistical significance was determined using the two-tailed
Student’s t test. Significant differences between groups are declared and denoted
as: * when p < 0.05 ; and ** when p < 0.01.
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Figure 2.2: Oct4 -GFP expression analysis using the Guava EasyCyte Plus bench
top flow cytometer. GFP+ expressing cells from control samples were identified and
gated into 50% high and 50% low expressing areas (Panel A). Gate settings from
the control samples were applied to treated samples to evaluate shifts in GFP+
expression (Panel B). In this example, 51% of GFP+ cells were recorded as high
GFP+ in the control sample, and 14% of GFP+ cells were recorded as high GFP+ in
the treated sample. The difference in values indicate a loss in high GFP+ expressing
cells.
39
2.3 Physical impact of centrifugation on mES cells
2.3 Physical impact of centrifugation on mES cells
This section of the chapter will first describe the theoretical considerations used in
the characterisation of the physical impact of centrifugation on mES cells and the
construction of a suitable window of operation. This is followed by the methods
describing how experimental data was obtained.
2.3.1 Theoretical considerations
2.3.1.1 Clarification
When allowed to stand under the influence of gravity over time, particles suspended
within a fluid will settle out of solution due to the density difference between the
solid and liquid phases. This process is called clarification and can be accelerated
by applying a centrifugal force to increase the particle settling velocity. To measure
clarification performance, the Sigma concept of equivalent settling area is commonly
used, and is an index of area that is equivalent to that of a settling tank capable
of the same particle separation performance under the influence of gravity (Ambler,
1961). Sigma concept is based on the Stoke’s definition of settling velocity of a
particle and assumes particles are present as single spheres in a dilute suspension
and that settling is unhindered. Stoke’s particle settling velocity is defined as:
us =
d2g
18µ
(ρp − ρf ) (2.2)
where us is the terminal settling velocity of the particle (m s
−1), d is the diameter
of the particle (m), g is the acceleration due to gravity at sea level (9.81 m s−1), µ
is the viscosity of the fluid the particle is moving through (N sm−2), ρp and ρf are
the particle and fluid density respectively (kg m−3).
The clarification capacity, C, (m s−1) of as centrifuge is defined as:
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C =
V
tc · Σlab (2.3)
where V is the volume (m3) of suspension being centrifuged, tc, is the overall cen-
trifugation time (s), and Σlab, is the theoretical equivalent separation area (m
2) for
recovery of 100% of particles for a laboratory bench top centrifuge corrected for
acceleration and deceleration phases as derived by Maybury et al. (2000):
Σlab =
V · ω2 · (3− 2x− 2y)
6g · ln
(
2r2
r2+r1
) (2.4)
where ω is the rotor angular velocity (s−1), x is the fraction of the overall time for
acceleration, and y is the fraction of the overall time for deceleration of the rotor.
r1 and r2 are the radii (m) of the surface of the centrifuge liquor and the base of the
centrifuge tube respectively. The relationship between ω and RCF is given by:
RCFmax =
ω2 · r2
g
(2.5)
where RCFmax is the maximum relative centrifugal force (g) and g is the acceleration
due to gravity at sea level (9.81 m s−2). The fraction of mES cells recovered, F , for
a given clarification capacity is given by:
F = 1− N1
N0
(2.6)
where N0 and N1 are the total cell counts in the supernatant before and after
centrifugation respectively. Clarification performance of the centrifuge is determined
by plotting F against clarification capacity on a probability-log scale.
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2.3.1.2 Cell recovery
Cell recovery after centrifugation was evaluated on a basis of cell numbers and %
cell viability. High cell numbers and % cell viability recovered are desirable as this
indicates a low level of cell damage during the centrifugation. % cell viability, ν, is
given by:
ν =
CV
CV + CN
× 100 (2.7)
where CV is the viable cell concentration (cells mL
−1), and CN is the non-viable cell
concentration (cells mL−1).
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Figure 2.3: Schematic representing the millilitre scale batch centrifugation proce-
dure used to investigate the impact of centrifugation on mES cells. Cell suspensions
of known cell concentration (C0) and cell viability (ν0) are subjected to centrifuga-
tion. The collected cell pellet is subsequently resuspended back into a known volume
of liquor under constant resuspension conditions. The cell concentration (C1) and
cell viability (ν1) of the resuspended liquor is evaluated and is used to determine
the impact of centrifugal force and centrifugation time on cell recovery. The cell
concentration (C ′1) and cell viability (ν
′
1) of uncentrifuged control samples of equiv-
alent time-temperature history are evaluated in parallel. Cell concentrations were
evaluated using bench top flow cytometry. Experiments were carried out at three
different process temperatures, 4, 21 and 37◦C.
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Figure 2.3 represents the millilitre scale batch centrifugation procedure used to
investigate the impact of centrifugation on cells. For cell recovery calculations, this
can be distinguished between a process and a centrifugation metric. The difference
between either metric lies within how time is considered within the system for a
given set of centrifugation conditions (RCF , T and tc). The centrifugation metric
takes into account the overall processing time for centrifugation and thus ignores cell
gains or losses due to time-temparature exposure. On the other hand, the process
metric accounts for all effects including holding time, centrifugation time and cell
resuspension losses. For instance, the fraction of cells lost from the process, FP , is
defined as:
FP =
C0 − C1
C0
(2.8)
and the fraction of cells lost after centrifugation, FC , is defined as:
FC =
C ′1 − C1
C ′1
(2.9)
where C0 is the initial concentration of total cells (cells mL
−1) in the sample before
centrifugation, C1 is the final concentration of total cells (cells mL
−1) in the sample
after centrifugation, and C ′1 is the final cell concentration of uncentrifuged cells
exposed to an equivalent time-temperature history as C1.
Similarly, calculations made on a % viability basis, ν, to determine the physical
change in state of cells during centrifugation can be defined for a process, FP,ν , and
centrifugation, FC,ν , metric and are given in equations (2.10) and (2.11):
FP,ν =
ν0 − ν1
ν0
(2.10)
and,
44
2.3 Physical impact of centrifugation on mES cells
FC,ν =
ν ′1 − ν1
ν ′1
(2.11)
where ν0 is the initial cell viability (%) in the sample before centrifugation, ν1 is
the final cell viability (%) in the sample after centrifugation, and ν ′1 is the final
cell viability (%) of uncentrifuged cells exposed to an equivalent time-temperature
history as ν1.
2.3.1.3 Window of Operation
The Window of Operation developed presents information with regards to centrifuge
performance and is constructed with a minimum acceptable level of clarification
and fraction of cell viability lost in mind. The two common performance criteria
identified in batch centrifugation that directly govern the interdependencies within
the system are time (t), i.e. overall centrifugation time (tc) characterised by time
taken for the centrifuge bowl to accelerate from rest to a set RCF value, the hold
time at the set value and the time taken for the centrifuge bowl to decelerate from
the set RCF value to rest, and relative centrifugation force (RCF ). These two
dimensions define the multivariable parameter space within which the window of
operation lies.
For clarification, the clarification performance, F , of a centrifuge is governed by
the relationship between the variables, C, tc and RCF and are specified in Equations
(2.3) and (2.4). When combined these give:
tc =
6g · ln
(
2r2
r2+r1
)
C · ω2 · (3− 2x− 2y) (2.12)
Equation (2.12) represents the relationship between RCF and tc for a user defined
minimum acceptable level of clarification (C).
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For cell recovery, the Fraction of cell viability lost is used to construct the second
minimum acceptable criteria used to characterise centrifuge performance. The frac-
tion lost in % cell viability data sets from the cell recovery experiments were plotted
in 3D Cartesian coordinates (x = t, y = RCF and z = ∆ν) for each temperature
condition, and imported into the surface fitting package. Three non-linear sigmoid
mathematical functions were explored to find a model to fit profile of each data set;
the functions were:
∆ν =
(
1− e−a·tc·RCFn)m (2.13)
∆ν = tanhm (a · tc ·RCF n) (2.14)
∆ν =
(a · tc ·RCF n)m
(a · tc ·RCF n)m + 1 (2.15)
where a, m and n are fitted coefficients and ∆ν is the fraction change in % cell via-
bility. The relationship between ∆ν and the two dimensions (RCF and t) that define
the multivariable parameter space is embodied in each function and they represent
the constraint that defines the limit of available centrifuge operating conditions for
a given user defined level of ∆ν. Each function satisfies the limit conditions:
∆ν = 0 , tc = 0 ∆ν = 0 , RCF = 0 (2.16)
∆ν → 1 , tc →∞ or RCF →∞ (2.17)
and have the profile:
δ∆ν
δtc
= 0 , tc = 0
δ∆ν
δRCF
= 0 , RCF = 0 (2.18)
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Surface fitting was achieved using a non-linear least square algorithm executed
in MATLAB R© (v7.3) to determine the value of coefficients in the proposed model.
The fitting algorithm was programmed to assume convergence when the difference
between successive iterative approximations was < 1 × 10−100. The goodness of fit
for each function explored was evaluated through the coefficient of determination
(R2) value given by:
R2 = 1−
∑n
i=1 (νi − f (∆νi))2∑n
i=1 (νi − ν¯)2
(2.19)
where νi is the actual fraction change in % cell viability for a given set of cen-
trifugation conditions, f (∆νi) is the predicted fraction change from the sigmoid
expressions evaluated, and ν¯ is the average of the predicted values.
2.3.2 Experimental design
The study of the physical impact of centrifugation is broken down into three major
experimental studies: (1) clarification; (2) cell recovery; and (3) cell damage, and
seeks to characterise different aspects of the centrifugation procedure by varying a
combination of RCF, T or tc. Cell suspensions for each study were prepared as
described.
Harvested mES cell suspension were adjusted to 4, 21 or 37◦C and a concentra-
tion of 1 × 106 cells mL−1 to provide the monodispersed cell suspension feedstock for
centrifugation. Feedstocks of < 95% cell viability as determined by flow cytometry
(see Section 2.2.3) were excluded from the studies. 1.7 mL of feedstock was then
aliquoted into the 2 mL micro-centrifuge tube containing a machined acrylic (see
Section 2.2.1 for description) insert ready for centrifugation.
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2.3.2.1 Clarification
Cell suspensions at 21◦C were subjected to the following centrifugation conditions:
for a constant t series, t = 2 min, for RCF = 40, 60, 100, 160, 200 and 240 g;
for a constant RCF series, RCF = 30 g, for t = 2, 4, 6, 10, 14, 16 and 20 min.
After centrifugation, the number of cells remaining in suspension within the super-
natant fraction was determined. Supernatant is defined as all the liquor contained
within the main cylindrical body and conical section of the centrifuge tube; sedi-
ment (together with its entrained liquor) is defined as the cell pellet found within
the well section of the machined insert within the 2 mL centrifuge tube. The influ-
ence of temperature on clarification was determined at 4 and 37◦C for centrifugation
conditions that achieve high levels of F (> 85%).
2.3.2.2 Cell recovery
Cell suspensions at 4, 21, and 37◦C were subjected to the following centrifugation
conditions: for a constant t series, t = 20 min, for RCF = 100, 200, 500, 1,000,
2,000 and 3,000 g; For a constant RCF series, RCF = 200 g, for t = 2, 5, 10,
20, 50 and 100 mins. After centrifugation, the collected cell pellet is resuspended
back into the same volume of liquor in situ and the cell density determined. The
resuspension regime is capable of dispersing the pelleted cells into a mono-dispersed
cell suspension and was kept constant across all cell pellet samples. The regime is
defined as follows using standard Gilson P1000 and P200 pipettors and pipette tips:
1. remove 1 mL of the supernatant from the tube,
2. with a 200 µL pipette tip, with pipettor set at 200 µL, gently triturate pellet
over 20 cycles,
3. with a 1,000 µL pipette tip, with pipettor set at 500 µL, gently triturate pellet
over 20 cycles,
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4. replace 1 mL of the withdrawn supernatant, and gently triturate a final 5
cycles with a 1,000 µL pipette tip, with pipettor set at 1,000 µL.
Gentle trituration refers to a situation where the pipettor’s push button was man-
ually cycled smoothly at a frequency approximating 1 cycle per second. Control
samples (5–7 mL) were exposed to the same time and temperature combinations,
and were mixed every 30 minutes using trituration with a standard 10 mL serological
pipette to minimise cells settling out of solution.
2.3.2.3 Cell damage
The centrifugation procedure can be broken down into a settling phase, where cells
settle out of solution and are collected in a pellet at the bottom of the tube when
centrifuged, and into a resuspension phase, where the collected cell pellet is dispersed
into a monosuspension in a volume of liquid (Fig. 2.3). Harvested cell suspensions
were centrifuged at 3,000 g × 20 mins at 4, 21 and 37oC. Samples of culture
medium immediately after the settling phase and resuspension phase were assayed
for lactate dehydrogenase (LDH) activity using the CytoTox-ONETMHomogeneous
Membrane Integrity Assay (Promega UK, Southhampton, UK ). Pelleted cells were
resuspended according to the regime outlined in Section 2.3.2.2. Negative control
uncentrifuged cell suspension were assayed alongside. Briefly, 100 µL of sample
culture medium was loaded into 96 black untreated microwell optical bottom plates
(Nalge Nunc International, New York, USA) and incubated with an equal volume
of CytoTox-ONETMReagent at 22 oC for 10 minutes. After incubation, the reaction
was quenched with 50 µL of supplied Stop Solution. The plates were measured in
a Tecan Sapphire II fluorometric plate reader (Tecan UK Ltd, Reading, UK) with
a 550/600 nm excitation/emission set point and a ±20 nm bandpass. Background
fluorescence of cell free culture medium was also measured. The values reported are
expressed in relative fluorescence units (RFU).
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2.4 The impact of centrifugation on the pheno-
type of mES cells
2.4.1 Experimental design
The following series of experiments were designed to investigate: (1) the impact of
centrifugation on mES cell pluripotency; and (2) the impact of centrifugation on the
differentiation potential of mES cells. Cell suspension feedstocks for centrifugation
studies were prepared in 2 mL centrifuge tubes as described in Section 2.3.2 on
page 47.
2.4.1.1 Undifferentiated expansion of mES cells study
Undifferentiated monolayer cultured Oct4 -GFP cells were harvested as described in
Section 2.2.2 and resuspended in complete medium adjusted to 21◦C. Cell suspen-
sion feedstocks were centrifuged at 500, 1,000, 2,000 and 3,000 g for 3 minutes. The
collected pellets were resuspended into a mono-dispersed cell suspension using the
pipetting regime outlined in Section 2.3.2.2 and plated onto pre-gelatinised 6 well
plates at 10,000 viable cells cm−2. Cultures were incubated under standard condi-
tions and culture medium for 2 days. Control cultures, i.e. not centrifuged, exposed
to the same ambient conditions and pipetting regimes were prepared alongside.
2.4.1.2 EB expansion and differentiation study
Undifferentiated monolayer cultured Oct4 -GFP were harvested as per Section 2.2.2
and resuspended in LIF free complete medium. The cell suspension was subse-
quently subjected to centrifugation at 21◦C for 20 minutes at 500, 1,000, 2,000 and
3,000 g. Cell pellets obtained were dispersed back into the supernatant in situ and
adjusted to 5 × 105 viable cells mL−1 for static suspension culture inoculation. The
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centrifuged cells were plated onto non-tissue culture treated PS vented 94 × 15 mm
petri dishes (Greiner Bio-One Ltd, Gloucestershire, UK) with a final inoculation vol-
ume of 15 mL. Cells were incubated at 37◦C, with a 7% CO2 content in air for 8 days
in suspension culture with medium exchanges every 2 days. Medium exchanges were
achieved by allowing embryoid bodies (EBs) to gravity settle in 25 mL centrifuge
tubes for 15 minutes. 1 mL EB samples were taken from each culture every 2 days
and dissociated with 0.1% trypsin (see Section 2.2.2 for preparation) before flowcy-
tometric analysis. 20 phase contrast images of cultures were taken on days 4 and 8
for each condition for image analysis. Control cultures, i.e. not centrifuged, exposed
to the same ambient conditions and pipetting regimes were prepared alongside.
2.4.2 Analytical techniques
2.4.2.1 Growth rates and doubling times
Growth rates and doubling times were calculated based on the exponential growth
phase of the culture. The specific growth rate is given by the following equation:
µ =
ln(C2)− ln(C1)
t
(2.20)
and doubling time is given by:
td =
ln(2)
µ
(2.21)
where C2 and C1 is the viable cell concentration at the end and start of the expo-
nential growth phase (viable cells mL−1), µ is the specific growth rate of the culture
(hours−1) and td is the culture doubling time (hours).
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2.4.2.2 EB image analysis
Phase contrast images of EBs were acquired every two days through the course of the
static suspension culture. (Nikon Eclipse TE2000-U inverted microscope equipped
with a Nikon SD-Fi1 camera (Nikon UK Ltd, Surrey, UK) and a 4× objective lens).
Resolution of the images obtained were 1,280× 960 pixels, corresponding to a field of
view of 2,190 × 1,620 millimeters. EBs were analysed using ImageJ processing and
analysis software v1.38x (available for download at: http://rsb.info.nih.gov/ij/ , US
National Institutes of Health) to count the number of EBs present and determine
their diameter. Imaged EBs with an area smaller than 1,250 µm2 were excluded
from analysis. This was to exclude background cell debris, single cells and small cell
aggregates.
2.4.2.3 Reverse transcription polymerase chain reaction and quantita-
tive polymerase chain reaction
Total RNA was isolated from cell pellets using the RNAqueous Kit R© (Applied
Biosystems, Warrington, UK) according to manufacturer’s instructions and con-
taminating genomic DNA was degraded using TURBO DNA-freeTMKit (Applied
Biosystems, Warrington, UK). A NanoDropTM1000 spectrophotometer (Thermo
Fisher Scientific, Leicestershire, UK) was used to assess RNA quantity and quality
(A260/A280 > 1.8). First strand random decamer primed cDNA was synthesised by
using the RETROscript R© Kit (Applied Biosystems, Warrington, UK) as described
by the supplier.
For reverse transcription polymerase chain reaction (RT-PCR) analysis, synthe-
sised cDNA was amplified in 25 µL volumes using the BIOTAQTMCore Kit (Bioline
Ltd, London, UK) and individual primer pairs for specific gene markers (Table 2.1).
After an initial 3 minutes denaturing step at 94.0◦C, reactions were cycled through
25—30 rounds of 94.0◦C for 25 seconds for denaturing, annealing temperature range
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of 55.0—60.0◦C for 20 seconds, and extension at 72.0◦C for 45 seconds. This was
followed by a final extension time of 5 mins. PCR products obtained were analysed
by agarose gel electrophoresis on 2.5% agarose gels stained with SafeViewTMNucleic
Acid Stain (NBS Biologicals Ltd, Cambridge, UK). The size of the amplification
bands was estimated using HyperLadderII (Bioline Ltd, London, UK. No reverse
transcription controls and no template controls were included to monitor for con-
tamination.
Quantitative polymerase chain reaction (qPCR) was performed in a Mastercycler R©
ep realplex4 (Eppendorf, Cambridge, UK) with QuantiTect R©SYBR R© Green RT-
PCR Master Mix (Qiagen, West Sussex, UK) and QuantiTect R© Primer Assay (Qi-
agen, West Sussex, UK) for specific gene markers (Table 2.1) with the following
cycling conditions: an initial activation step 95.0◦C for 15 minutes followed by 40
cycles of 94.0◦C for 15 seconds, 55.0◦C for 30 seconds and 72.0◦C for 30 seconds.
Melting curve analysis of the PCR products were performed to verify their specificity.
The relative expressions of gene targets were normalised to β-actin and calculated
using the 2−∆∆CT method (Livak & Schmittgen, 2001). Amplification efficiency rep-
resentative for each gene specific QuantiTect R© Primer Assay kit was determined
using 10-fold dilution standard curve. For all gene targets investigated, the average
efficiency was 0.998 with a < 10% coefficient of variance.
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Table 2.1: List of gene specific targets for RT-PCR and qPCR. RT-PCR primer pair
sequences are depicted in 5′ to 3′ direction.
RT-PCR
Gene Accession # Primer sequence Amplicon (bp)
Oct4 NM 013633 F: CAGCCAGACCACCATCTGTC 138
R: GTCTCCGATTTGCATATCTCCTG
Nanog NM 028016 F: TTGCTTACAAGGGTCTGCTACT 106
R: ACTGGTAGAAGAATCAGGGCT
Rex1 NM 009556 F: TGGAAGCGAGTTCCCTTCTC 128
R: GCCGCCTGCAAGTAATGAG
β-actin NM 007393 F: CAACGAGCGGTTCCGATG 67
R: GCCACAGGATTCCATACCCA
qPCR
Gene QuantiTect R© Primer Assay Cat. #
Oct4 QT00109186
Nanog QT01076334
Utf1 QT00252112
Sox17 QT00160720
T QT00094430
Tubb3 QT00124733
β-actin QT01136772
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Chapter 3
Results and Discussion:
Physical Impact of Centrifugation
on mES Cells
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3.1 Introduction
Two major sets of results are reported in this chapter and they relate to the study
of centrifuge clarification performance (see Section 3.2) and cell damage during cen-
trifugation (see Section 3.3). The results obtained were used to construct a Window
of Operation defining an optimum operating region for centrifugation of mES cells.
3.2 Centrifuge clarification performance
Centrifuge clarification performance was established based on a cell concentration
of 1 × 106 cells mL−1. The inverse relationship between clarification capacity (C)
and fraction of total cells (total cells = viable cells + non-viable cells) recovered (F )
is shown in Figure 3.1 and this represents the clarification performance of the batch
centrifuge when operated at 21◦C. Clarification capacity limits were established
empirically to correspond to a useful range of F values (∼ 30–95 %). The clarification
capacity was adjusted by varying time (t = 2–20 mins) at constant RCF (g = 30)
conditions, and varying RCF (RCF = 40–240 g) at constant time (t = 2 mins)
conditions. Establishing limits on the clarification capacity was useful in avoiding
over-centrifugation of the cell suspension as the mES cells could be sensitive to the
mechanical forces applied. In contrast, under-centrifugation of the cell suspension
would result in a significant loss of mES cells to the suspending liquid resulting in
poor clarification. The range of centrifugal conditions examined was between 60–600
gmins. In order to achieve a minimum of 90% recovery in cells, samples have to be
exposed to a minimum of 300 gmins (i.e. top 3 F -values for either series examined).
For example, 300 gmins is equivalent to centrifugation at 150 g × 2 mins or 100 g
× 3 mins.
Imposing a linear relationship on the data set yields a satisfactory fit (R2 =
0.873). The trend of data points where F > 0.8 indicates higher levels of cell re-
covery requires a disproportionately greater level of centrifugation when compared
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to lower levels of cell recovery. This is likely to be an artifact of the assumptions
used when applying Sigma concept. Sigma concept is based on Stoke’s definition
of settling and assumes unhindered settling of a spherical particle within a homoge-
nous gravitational field. In practice, the cells in suspension are a distribution of
sizes about a mean cell size of 13 µm (measured using Cedex HiRes automated cell
counter), and settling is hindered due to the high concentration of cells accumulat-
ing at the bottom of the tube. The centrifugal field within the centrifuge tube is
not homogenous because: (1) we assume constant centrifugal acceleration based on
ω2·r2
g
(see Eqn. (2.5)), where r2 is the outer radius of the centrifuge tube, and (2) the
direction of centrifugal forces within the tube do not act in parallel to the walls of
the tube, resulting in a proportion of cells that collide with the tube walls due to the
radiality of the centrifugal force. The calculated clarification capacity (C) for a 99%
recovery of cells is 7.77× 10−7 m s−1 and is based on the linear fit. This value will
be used in a following section (see Section 3.4) to construct a Window of Operation.
Incidentally, the maximum value of F that can be determined experimentally is 0.99
or 99.0%, and is imposed by the detection limit of the Guava Instrument.
As the fraction of mES cells recovered is calculated from the cells remaining
within the supernatant fraction (see Eqn. (2.6)), no comments will be made on the
state of mES cells collected in the cell pellet at this juncture. This is addressed
in Section 3.3.2 as cells could be viable or rendered non-viable or destroyed by the
applied centrifugal force. Throughout the experiment it was noticed that the cell
pellets became more tightly packed as centrifugal force and time were progressively
increased (C → 10−7 m s−1). In order to minimise disturbances to the cell pellet
collected by flow eddies generated during sampling, the supernatant from each cen-
trifuge tube was carefully removed using a pipette. In particular, with the pipette
tip held below the fluid meniscus, supernatant was withdrawn gently from the cylin-
drical and conical sections of the centrifuge tube only. No fluid was withdrawn from
the well section of the machined acrylic insert which contains the cell pellet.
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Figure 3.1: Centrifuge clarification performance determined on a total cells basis
(viable and non-viable cells). Cell suspensions at 21◦C were centrifuged by varying
time at constant RCF (g = 30) conditions (N), and varying RCF at constant time
(t = 2 mins) conditions (◦). F , fraction of cells recovered was evaluated on the
number of cells that remained in the supernatant fraction of the liquor. The solid
line represents a linear fit for all experimental data points (R2 = 0.873), the dashed
and dotted lines are the 4 and 37◦C corrections for this line. The calculated C value
for a 1% loss in recovered cells is 7.77 × 10−7 m s−1. Results are mean ± 2SE for 6
independent samples for each centrifugation condition.
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3.2.1 Theoretical analysis of cell settling in centrifugal field
In this subsection, a simple model for cell settling in a centrifugal field was developed
using Equation (2.2) and the results from Figure 3.1. Centrifuge clarification perfor-
mance data was transformed into a log-normal distribution by plotting changes in
fraction of cells recovered (dF ) against an appropriate range of clarification capacity
values (C) which were divided into 100 equal steps (Fig. 3.2A). The distribution
obtained corresponds to a range of 0.001 ≤ F ≤ 0.999 values and was established
from the linear fit of the experimental data points in Figure 3.1. The gradient of
the linear fit line determines the shape of the distribution; a steep gradient results
in a narrow spread and a shallow gradient results in a broad spread.
As clarification capacity (C) and Stoke’s terminal settling velocity of a particle
(us) are dimensionally similar (m s
−1), Figure 3.2A also depicts the distribution of
settling velocities of cells within the centrifugal field (cells are assumed to behave like
spherical particles). In addition, it also represents the distribution of cell sizes within
the population of cells subjected to centrifugation as us is proportional to cell size
(i.e. C ∝ us ∝ d). Using Equation (2.2), the mean cell size of the cell population can
be determined from the information presented in Figure 3.2A and literature values.
For example, the expected mean cell diameter of the cell population corresponds
to a 50% recovery in cells. Thus, when F = 0.5, C = 7.67 × 10−6 m s−1 and this
corresponds to the peak observed in the distribution (Fig. 3.2A). Feeding C =
7.67× 10−6 m s−1 and literature values for µ, ρp, ρf , and solving for d in Equation
(2.2) (µ21oC = 0.979× 10−3 N sm−2, and ∆ρ = 20 kg m−3), the mean cell diameter
was calculated to be 13 µm. This value is concordant with the known mean cell
diameter of Oct4-GFP cell populations.
The distribution of cell settling velocities at 4 and 37oC process temperatures
were determined using Equation (2.2) and varying fluid viscosity (Fig. 3.2B) (µ4oC =
1.969× 10−3 N sm−2 and µ37oC = 0.692× 10−3 N sm−2). A decrease in process tem-
perature from 21 to 4oC results in a corresponding decrease in cell settling velocities.
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This is due to the increase in viscous drag associated with the decrease in process
temperature. The effect of viscous drag on cell settling velocities is decreased when
the process temperature is raised from 4 to 37oC. The effects of temperature on cell
physiology and cell size were assumed to be negligible. The distributions obtained for
4 and 37oC process temperatures were mapped onto the probability-log centrifuge
clarification performance plot (Fig. 3.1) and maybe used to predict clarification
performance at various process temperatures (Table 3.1).
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Figure 3.2: The clarification capacity distribution was obtained by plotting changes
in fraction of cells recovered (dF ) against an appropriate range of clarification values
(C) which were divided into 100 equal steps (Panel A). As C and Stoke’s particle
settling velocity, us are dimensionally similar, the distribution obtained is also in-
dicative of the cell size distribution. Although only experimental data was available
for F values within a range of ∼0.30–0.99, the distribution represented corresponds
to 0.001 ≤ F ≤ 0.999 values. The influence of process temperature was assumed
only to affect fluid viscosity and the clarification capacity distribution was corrected
accordingly using Equation (2.2) (Panel B). The solid line represents the distribu-
tion at 21oC, and the dashed and dotted lines are the 4 and 37oC corrections for
this line.
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3.2.2 Influence of temperature variations
The influence of process temperature variation on clarification performance at high
levels of cell recovery (F > 85%; 30 g × 10 mins; Σ = 1.88 × 10−6 m s−1) is
summarised in Table 3.1. The table also includes predicted cell recovery values
at the various process temperatures examined. Temperature was assumed to only
affect the viscosity of the suspending liquor within the system and its effect on cell
physiology to be negligible. Statistical testing (two-tailed Student’s t test) to a 95%
confidence revealed that the difference in F between 21 and 4◦, and 21 and 37◦
were not significant. The temperature-viscosity profile for complete medium was
assumed to be equivalent to that of water (Radisic et al., 2005), and corrections for
4 and 37 ◦C to the 21◦C fitted line were made and plotted in Figure 3.1 (see Section
3.2.1). All but one of the data points are spread between in the 4 and 37◦C degree
boundaries, further reinforcing that temperature variations do not have a significant
effect on clarification performance. This analysis was confined to high levels of cell
recovery not because the influence of temperature at low levels of cell recovery are
large on F , but because low levels of cell recovery in practice are not desirable. The
predicted F values for three process temperatures examined varied no more than
7% from the obtained experimental value. Although simple, the clarification model
was able to give fairly accurate results because it was informed with experimental
data (i.e. 21oC F data) and the contributions of fluid viscosity changes with respect
to temperature variations were significant.
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Table 3.1: Table summarising the influence of temperature on clarification perfor-
mance of the centrifuge operating at fixed Sigma value of 1.88× 10−6 m s−1 at high
cell recoveries (F > 85%). There were no significant differences between operations
at 21 and 4 ◦C, and 21 and 37◦ at the 95% level of confidence. The table also in-
cludes predicted F values generated from the simple clarification model developed.
The differences between predicted and experimental F values (≤ 7%) suggest that
the model is able to give fairly accurate predictions. Results are mean ± 2SE for 6
independent sample for each condition.
F
Temperature (◦C) Predicted Experimental p-value
4 0.814 0.876 ± 0.0114 0.160
21 0.923 0.896 ± 0.0240 –
37 0.957 0.938 ± 0.0105 0.0527
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3.3 Centrifugal cell recovery
This section examines the effect of centrifugal force, centrifugation time and the
associated cell pellet resuspension procedure on mES cells during processing. For
every centrifuged cell sample exposed to a combination of centrifugal force, time
and process temperature, an equivalent (uncentrifuged) control sample was assessed
in parallel. Each sample was evaluated for Fraction of cells lost and Fraction of
cell viability lost as measures of cell damage. The former metric is indicative of the
absolute recovery of all cells detected (viable and non-viable cells) after centrifugal
processing, and the latter is indicative of the change in state of cells from that
particular sample.
The influence of time and temperature on the control samples are shown in
Figure 3.3. Note that on the expanded y-axis scale positive values reflect an overall
loss in cell numbers or cell viability, and negative values reflect an overall gain in cell
numbers or cell viability. Differences between initial and final values for cell numbers
and cell viability for each condition were tested to the 95% level of confidence and
hence are highlighted as significant changes from the initial sample. Only 4 samples
showed such a significant change.
A significant gain in total cells (Fig. 3.3 A) and a significant loss in cell viability
(Fig. 3.3 B) at 100 minutes of all three of the holding temperature was registered.
A significant loss in cell viability was also observed in the sample held for 50 mins at
37◦C. Results for the remaining control samples suggest that experiments to study
the effects of recovery conditions on the cells can be assessed as having the same
initial cell concentrations and viabilities as the initial start material at least for hold
time up to 20 minutes and possibly up to 50 minutes for 4 and 21◦C. The use of
lower temperatures does not significantly affect cell concentration and viability.
The results for Fraction of cells lost and Fraction of cell viability lost for cen-
trifuged mES cell samples is presented in Figure 3.4 and Figure 3.5 respectively
64
3.3 Centrifugal cell recovery
(Note the difference in y-axis scale between Fig. 3.3; 0—0.1, and Fig. 3.4 and 3.5;
0—1.0).
Both measures of cell damage were further evaluated on a process (Panels A &
B in Fig. 3.4 and 3.5) and a centrifugation (Panels C & D in Fig. 3.4 and 3.5) basis.
The difference between evaluation on a process and centrifugation basis lies within
how time is considered with in the system for a given set of centrifugation conditions
and is detailed in Section 2.3.1.2. Briefly, the centrifugation metric take into account
the overall processing time for centrifugation and thus ignores cell gains or losses due
to time-temperature exposure. On the other hand, the process metric accounts for
all effects including holding time, centrifugation time and cell resuspension losses.
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Figure 3.3: Impact of time-temperature on mES cells held in suspension. These
results serve as controls to centrifuge samples. mES cell suspensions at 1 × 106
cells mL−1 were subjected to various time-temperature combinations to determine
Fraction of cells lost (Panel A) and Fraction of cell viability lost (Panel B). Signifi-
cant differences between initial and final values for each time-temperature exposure
combination are indicated with * or ** denoting p > 0.05 and p > 0.01 respectively.
Results are mean ± 2SE for 6 independent samples.
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Figure 3.4: Impact of centrifugation time, process temperature and centrifugal force
on mES cell numbers. mES cell suspensions were centrifuged by varying time at
constant RCF (RCF = 200 g) conditions (Panels A & C), and varying RCF at
constant time (20 mins) conditions (Panels B & D). The fraction of cells lost was
evaluated on both a process (FP ; Panels A & B), and centrifugation (FC ; Panels
C & D) basis. A 5–25% average cell loss occurring at all process temperatures
and centrifugation conditions was observed, with losses peaking in high time and
temperature combinations. Results are mean ± 2SE for 6 independent samples.
67
3.3 Centrifugal cell recovery
Figure 3.5: Impact of centrifugation time, process temperature and centrifugal force
on mES cell viability. mES cell suspensions were centrifuged by varying time at
constant RCF (RCF = 200 g) conditions (Panels A & C), and varying RCF at
constant time (20 mins) conditions (Panels B & D). The fraction of cell viability
loss was evaluated on both a process (FP,ν ; Panels A & B), and centrifugation (FC,ν ;
Panels C & D) basis. The results indicate that cell damage is dependent on a
combination of centrifugal force, centrifugation time and temperature. Results are
mean ± 2SE for 6 independent samples.
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3.3.1 Cell damage and the influence of process temperature
The degree of cell damage that occurs is measured by Fraction of cells lost and
Fraction of cell viability lost. The former is characterised by the complete destruction
of the cell plasma membrane resulting in the loss of intracellular contents to the
surrounding medium (Al-Rubeai et al., 1995). The latter is characterised by an
increased permeability in cell membrane and its inability to mediate the flow of ions
and molecules in and out of the cell whilst still maintaining the physical appearance
of a viable cell; these cells are termed non-viable cells. In this study, the measure of
Fraction of cell viability lost is in addition to the measure of Fraction of cells lost, as
latter only declares the remaining population of cells after destructive cell damage
and give no indication to the relative population of viable and non-viable cells.
Varying degrees of cell damage was detected in all centrifuged cell samples ex-
posed to the different centrifugation conditions. Figure 3.4 illustrates the Fraction
of cells (total cells) lost (i.e. total damage of cell plasma membrane) after cen-
trifugation. In general, 5—25% of cells are lost depending on centrifugation time,
processing temperature and centrifugal force. When considering cell loss as centrifu-
gation time and relative centrifugal force is increased (Fig 3.4 C & D), a possible
tendency for greater cell loss was noted as centrifugation time is increased to 100
mins when cells are processed at 21 and 37◦C (Fig 3.4 C). The cell losses incurred in
the remaining conditions were comparable to each other as RCF and centrifugation
time were progressively increased.
Further to this observation, there is some possible evidence to suggest that pro-
cessing cells at 21◦C results in lower cell losses compared with processing at 4 and
37◦C when the following rule is considered: Cells are not lost when the error bar for
each respective condition crosses or touches the baseline FP = FC = 0. Where the
error bar represents the range of values the calculated loss will lie for 95% (±2SE)
of the time. From the data set, the synergistic effects of centrifugal force, centrifu-
gation time and processing temperature on destructive cell damage may be ranked
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in the following order of priority in terms of determining the extent of cell damage:
time (≥ 100 mins)  temperature  relative centrifugal force.
The extent of cell damage was assessed in the remaining recovered cells from
each sample and is presented in Figure 3.5. In contrast to total cell loss data
(Fig 3.4), there is a clear correlation between loss of cell viability and centrifugal
force, centrifugation time and processing temperature. The relationship appears to
manifest as a sigmodial function of the process variables. To explore this further it
is valuable to look at the data for each temperature (Fig. 3.5 C & D):
At 4◦C, cell viability losses were low across the board for both the varying time
conditions at constant RCF, and varying RCF conditions at constant time. The loss
in cell viability averaged 3%.
At 21◦C, the largest change in cell viability was recorded at the highest levels
of centrifugation time and force, 49 and 25% respectively (Fig 3.5 C). These values
represent a magnitude increase in loss of cell viability over the losses observed at
4◦C.
The greatest loss in cell viability was observed when cells were centrifuged at
37◦C at the highest levels of centrifugation time and force, 76 and 64% respectively
(Fig 3.5 D). When compared to the losses incurred at 21◦, this is a 2.6 and 1.5-fold
increase in fraction change of cell viability. The discrepancy between the values
suggest that at extended centrifugation times at 21 and 37◦C, the time dimension
plays a crucial role in determining the the cells’ susceptibility to damage.
Finally, at centrifugation times 6 20 mins and forces 6 500 g, low levels of
change in cell viability are recorded across all process temperatures investigated.
These two values serve as a practical upper limit for batch centrifugation and are
used in Section 3.4.2 to aid in constructing of a window of operation for centrifugal
cell recovery.
To recapitulate, the combined effects of low process temperature, low centrifugal
force and short processing times result in low or no loss of cell viability. Low process
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temperature minimises the extent of cell viability loss that occurs as centrifugation
time or centrifugal force is increased.
No differences between cell damage (both viable cells lost and cell viability lost
considerations) evaluated on a process and centrifugation basis was observed. The
effects of cell gain or loss due to time-temperature exposure are ignored when eval-
uated on a centrifugation basis. Results from the experimental controls (Fig. 3.3)
indicate that no significant changes in the mES cell suspension occurred up to 50
mins. The absence of any changes in cell number and cell viability effectively causes
the process calculations to behave like the centrifugation calculations. However, at
100 mins, where a gain in cell numbers and a loss in cell viability was observed in the
controls, the expected differences between either basis of calculation was not evident
in the experimental results. This is likely due to a combination of large experiment-
to-experiment variations and small gains and losses observed in the controls.
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3.3.2 Lactate dehydrogenase activity
In order to evaluate where mES cells were being damaged during centrifugation,
intracellular LDH released from damaged cells into the surrounding culture medium
was monitored (Fig. 3.6). LDH activity was assayed in: (1) the supernatant frac-
tion of the sample after centrifugal exposure (3,000 g × 20 min), and (2) the culture
medium after pellet resuspension. Control samples were exposed to the same resus-
pension regime were also assayed.
Overall, the amounts of LDH detected within the control and supernatant sam-
ples were independent of the effects of temperature. The amounts of LDH detected
within the supernatant samples were low and comparable to background values. The
average values recorded across all three process temperatures examined for control
samples was 330 RFU and 46 RFU for supernatant samples. The differences be-
tween the control and supernatant readings indicate that resuspension is responsible
for cell damage.
LDH activity indicates for resuspended cell samples the degree of cell damage
incurred during resuspension is dependent on process temperature. At 4◦C, the
amount of LDH detected from the resuspended sample (390 RFU) was not dissimi-
lar to the value recorded for the control sample (360 RFU) at the same temperature.
However, as process temperature was raised, increasing amounts of LDH was de-
tected in the resuspended cell samples. At 21◦C a value of 700 RFU was recorded,
and 1720 RFU at 37◦C. This increase corresponds to a 1.2 and 4.4 fold increase in
LDH detected on 4◦C. The data indicates that exposure of cells to a centrifugal field
causes little or no damage, and resuspesnion operations together with increasing
process temperatures account for the majority of the damage.
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Figure 3.6: Contributions of centrifugal force and cell pellet resuspension to cell
damage. mES cell samples were centrifuged at 3000 g for 20 mins at 4, 21 and
37◦C. Supernatant samples were aspirated from the clarified medium immediately
after centrifugation and assayed for LDH release. Resuspended cell samples were
pellets resuspended back into the clarified supernatant in situ under constant resus-
pension conditions and assayed for LDH release. The data indicates the majority
of cell damage occurs during resuspension and that cell damage increases with in-
creasing temperature. Control samples not exposed to centrifugation (RCF = 1 g;
t = 20 mins) of equivalent time-temperature history were subjected to the same
constant reuspension conditions, as was supernatant samples. Control samples were
significantly different from supernatant samples, and resuspended samples with the
exception of 4◦C. Results are mean ± 2SE for 6 independent samples.
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3.4 Constructing a window of operation
By predicting the clarification performance for the centrifuge and the amount of
cell damage encountered for a specific set of centrifuge conditions, a Window of
Operation for centrifugal recovery of mES cells was developed. The results from
Figures 3.1 and 3.5 C & D together with equipment operating conditions in Table
3.2 were applied in constructing the window of operation.
Centrifuge clarification performance (Fig. 3.1) was evaluated to determine the
relationship between clarification capacity (C) and fraction of cells recovered (F ).
This relationship governs the amount of cells that settle out of its suspending liquour
for a given combination of centrifugal force (RCF) and centrifugation time (tc).
Based on this relationship and for a minimum acceptable value of 99% recovery of
cells (F = 0.99), a centrifuge clarification capacity of 7.77 × 10−7 m s−1 has to be
achieved. This value was then used to calculate a corresponding set of centrifugation
conditions (RCF and tc) using Equations (2.3) and (2.4). Combining both equations
and solving for centrifugation time (tc) gives Equation (2.12), thus a corresponding
range of centrifugation time (tc) can be obtained over a range of relative centrifugal
forces (RCF). In this instance a range of 0—3000 g was used in the calculations.
Figure 3.8 A illustrates the plotted set of RCF and tt values; when operating to
the right of this clarification line (shaded area) the minimum acceptable level of cell
recovery is exceeded.
To construct the line representing the minimum acceptable level of Fraction of
cell viability lost in the window of operation, a relationship between centrifugation
force (RCF), centrifugation time (tc) and Fraction of cell viability lost (FP,ν or FC,ν)
has to be established. Equations (2.13), (2.14) and (2.15) were examined to deter-
mine their suitability in modeling the required relationship between the cell viability
and the centrifugation variables. Each function assumes a sigmoid shape and a 1st
order dependence on time, and no change in cell viability when not exposed to cen-
trifugation (i.e. FP,ν or FC,ν = 0, when tc = 0 or RCF= 0). No attempt was made
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to include in the model a function to allow for the influence of temperature on cell
viability. Hence the Fraction of cell viability lost results was modeled as discrete
temperature data sets.
3.4.1 Model development
The Fraction of cell viability lost evaluated for centrifugation was used to explore the
relationship between FC,ν , RCF and tc. The data together with preliminary range
finding data for each process temperature investigated (n = 12 + 6 independent
data points per process temperature) was organised into 3D Cartesian coordinates
(x = t, y = RCF and z = ∆ν, the Fraction change in cell viability) and the three
different equations being examined (Eqn. (2.13), (2.14) & (2.15)) were used to
convert the data.
Initial analysis revealed that the 1-exp function (Eqn. (2.13)), and the Michaelis-
Menten type function (Eqn. (2.15)) and was best suited to describe each tempera-
ture profile (R2 = 0.965 both functions where the R2 value is the arithmetic mean
value obtained over the 3 temperature fittings). The tanh function was excluded
from further analysis due to its lower coefficient of determination (R2 = 0.960), poor
fit to the data set (Fig. 3.9 C & D), and due to the low incidence of such functions in
biological systems. Although the 1-exp and Michaelis-Menten type functions have
been applied to modeling growth, mass transport and enzyme kinetics, the former
function was selected over the latter on the basis of simplicity and its better fit at
low levels of cell damage (Fig. 3.9).
The line representing the minimum acceptable level of fraction of cell viability
lost in the window of operation was determined for each process temperature and
plotted. The plotted lines revealed a smaller area of available centrifuge operating
conditions for 21◦C when compared to operation at 37◦C. This was contrary to the
expectation that a reduction in process temperature has the effect of enlarging the
operating area. The plotted operating area for the 4◦C data set was the largest of
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the three investigated temperatures. This unexpected result between the 21 and
37◦C operating areas was traced back to the number of degrees of freedom provided
in the 1-exp function. The discrepancy between the available operating areas of 21
and 37◦C was resolved by reducing the number of degrees of freedom in the 1-exp
function—from 3 to 1. This was acheived by applying the n and m coefficients
determined at 37◦C to the 4 and 21◦C model to give:
∆ν =
(
1− e−a·tc·RCF 0.6
)4.3
(3.1)
Where a is the coefficient to be determined by the fitting algorithm. Table 3.3
summarises the value of coefficients evaluated for each temperature fit, and Figure
3.11 illustrates the fitted 3D profiles for each temperature data set. The performance
of the 1-exp model was evaluated by charting the predicted model results against
the actual experimental results for all temperatures in a parity plot (Fig. 3.10).
The parity plot returned a goodness of fit coefficient of R2 = 0.940. The parity
plot suggests that the model underestimates the level of damage for a change in cell
viability when less than 10%.
Using Equation (3.1) and the determined coefficients given in Table 3.3, a set
of RCF and tc values can be obtained for a minimum acceptable level of fraction
of cell viability lost in the window of operation. Panel B in Figure 3.8 illustrates
the plotted set of RCF and tt values for a 1% loss in % cell viability at 21
◦C; when
operating to the left of this line (shaded area) the minimum acceptable level of loss
in cell viability after centrifugation is exceeded.
A thermodynamic assessment of the loss in cell viability during the cell resus-
pension can be performed with the fitted coefficient a from the 1-exp function when
plotted in the Arrhenius form (Fig. 3.7)—where the logarithm of the determined
rate constant, a, is plotted on the ordinate against the reciprocal of of the absolute
temperature on the abscissa. The assessment provides a simple way to explain the
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non-linear relationship between temperature and loss in cell viability during cell re-
suspension. The fitted line (R2 = 0.988) had a slope of -4,707.6 and corresponds to
a calculated calculated activation energy (Ea) of 3.9 × 107 J kmol−1. This value is
proportional and within cited activation energies for thermal cell growth.
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Table 3.2: Centrifuge characteristics and limits applied when generating the cen-
trifuge clarification performance constraint (see Eqn. (2.12)). x and y represent
the fraction of overall centrifugation time for acceleration and deceleration of the
centrifuge rotor respectively. Centrifuge rotor acceleration and deceleration times
were determined empirically for each RCFmax set point.
Description Value Units
Centrifuge characteristics
Volume 1.70× 10−6 m3
r1 0.131 m
r2 0.163 m
x 0.03 – 0.60 no units
y 0.04 – 0.70 no units
Constraints
RCF 0 – 3,000 g
Maximum yield (F ) 0.99 no units
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Table 3.3: Table summarising curve fitting coefficients used in the 1-exp model. n
and m coefficients remain constant and are based on the values generated from the
37◦C fit.
Temperature (◦C) a ×10−3 n m R2
4 0.18 0.6 4.3 0.951
21 0.57 0.6 4.3 0.923
37 1.08 0.6 4.3 0.964
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Figure 3.7: Thermodynamic assessment of the loss in cell viability during the resus-
pension process. The fitted coefficient a, from the 1-exp function was plotted in the
Arrhenius form. The calculated activation energy (Ea) for the process is 3.9 × 107
J kmol−1
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Figure 3.8: Operating constraints for constructing a window of operation for the
centrifugal recovery of mES cells. The constraints are plotted for a 99% recovery
of cells during clarification (Panel A), and a 1% loss in cell viability during cen-
trifugation (Panel B) at 21◦C. The shaded areas represent the available centrifuge
operating conditions that meet or exceed the requirements.
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Figure 3.9: Model development to predict the Fraction of cell viability lost during
centrifugation. 3 mathematical functions were explored to best fit the data set: 1-
exp (Panels A & B), tanh (Panels C & D), and Michaelis-Menten (Panels E & F).
The 1-exp function was selected over the tanh and Michaelis-Menten functions due
to its simplicity and its better fit at low levels of cell damage.
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Figure 3.11: 3D plot of modeled Fraction of cell viability lost response surface for
centrifugation at 4◦C (bottom), 21◦C (middle) and 37◦C (top). The coloured spots
on the mesh mark the the position of actual experimental data and its deviation
from its predicted value as indicated in the colour bar.
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3.4.2 Influence of processing temperature
A Window of Operation is constructed by superimposing lines which represent a
minimum acceptable level of centrifuge performance onto common axes. Figure 3.12
illustrates the influence of processing temperature on the Window of Operation for
centrifugal recovery of mES cells. Line (i) represents the clarification performance
of the centrifuge and operating to the right of this line exceeds the requirement to
recovery 99% of centrifuged cells. Line (ii) represents the fraction of cell viability
lost during centrifugation and operating to the left of this line satisfies the require-
ment that there is a 1% or less change in cell viability during the centrifugation
procedure. The L-shaped lines (i) and (ii) confine the unavailable and available
operating conditions along the ordinate and abscissa of the plots respectively (Fig.
3.8A & B). When lines (i) and (ii) superimposed on each other, the area bounded
by the elbows of both L-shaped lines suggest that for a given range of t values,
there is large range of available RCF values that can be chosen from to satisfy the
imposed minimum acceptable level of centrifuge performance. This is in contrast
to the available operating conditions along the vertical and horizontal arms of the
L-shaped area bounded by lines (i) and (ii). Operating along the tapered arms lim-
its feasible operating conditions to narrow ranges of RCF or t to a correspondingly
large range of t and RCF values respectively. The vertical and horizontal lines (iii)
and (iv) represent the practical time (20 mins) and centrifugal force (500 g) upper
limits for centrifugation.
In all cases, line (i) representing centrifuge clarification performance was pre-
sumed to be insensitive to changes in process temperature as indicated in the results
in Table 3.1. When considering the influence of process temperature on the window
of operation constructed by lines (i) and (ii), as processing temperature is raised,
the area of the window decreases corresponding to a decrease of available centrifu-
gation conditions. This decrease is brought about by the susceptibility of cells to
non-destructive cell damage (cell viability losses) as temperature is increased. This
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operating window can be further reduced by imposing practical centrifugal oper-
ating limits on time and centrifugal force; lines (iii) and (iv) respectively. When
considering the sensitivity of the operating region bounded by lines (i), (ii), (ii) and
(iv) to varying process temperatures, the available centrifuge operating conditions
for processing cells at 4 and 21◦C are similar and is approximately reduced by a
third when processed at 37◦C.
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3.5 Discussion
The physical impact of centrifugation on mES cells was examined by quantifying
the degree of cell damage incurred during processing. Comparisons in cell concen-
tration and cell viability before and after centrifugation provided the necessary cell
damage information; the former indicative of destruction to the cells, and the latter
indicative of the ratio between viable cells and non-viable cells in the remaining
intact cell population. It was recognised early during preliminary centrifugation ex-
periments that after centrifugation, it was inevitable that resuspension followed to
disperse the collected cell pellet. The differing contributions of cell damage due to
centrifugation, and due to resuspension were studied to some extent via monitoring
LDH activity in the surrounding culture medium immediately after centrifugation,
and after pellet resuspention. Although by this measure, the cells in the collected
cell pellets were not directly damaged by centrifugal force (Fig. 3.6), it is probable
that damage during resuspension is determined by the centrifugal force, centrifuga-
tion time and process temperature. Physical damage to cells in the collected cell
pellet only occurred when they were exposed to the shear environment created to
resuspend the cells after centrifugation. As the pipettor is cycled to disperse the
pellet, a jet flow is established as fluid passes to and fro through the pipette tip.
Cell damage is presumed to be caused by a combination of the energy dissipation
rates encountered in the jet flow and elongation of cells and cell aggregates passing
through the pipettor tip. The shear environment created by repeated cycling of the
pipettor for each cell pellet sample was maintained at the same level, i.e. all samples
were exposed to a similar resuspension/shear regime. It is appropriate to mention
at this juncture the utility of the LDH activity assay in relation to bioprocessing.
Unlike traditional methods of cell damage assay (e.g. trypan blue, PI staining)
where cells –damaged or otherwise– have to be physically present to be quantified,
the LDH activity assay allows for the level of cell damage to be determined without
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cells having to be present. This is particularly useful in situations where cell sam-
ples are precious, limited or where cell samples are not available—situations that
are commonly encountered during ES cell bioprocessing.
To help explain the results and facilitate the discussion of the likely processes
that contribute to cell damage, an understanding of the events that occur at the
cellular level has to be established, in particular, what is happening to and at the
cell membrane. Born et al. (1992) and Zhang et al. (1993) reported that cell dam-
age in laminar and turbulent flow is brought about by deformations caused to the
cell membrane by: (1) the applied shear stress causing cells to form into prolate
ellipsoids; and (2) eddies of sizes similar to or smaller than the cell interacting lo-
cally with the cell membrane. Cell damage occurs when these deformations cause
a rise in cell membrane tension that exceeds the cell bursting membrane tension.
In the cell pellet where cells are in close proximity to each other, membrane me-
diated intracellular adhesion events take place. The initial adhesion event is weak
and reversible, and subsequent stabilisation of the adhesion is metabolically driven
(Umbreit & Roseman, 1975). The stabilisation events are also time and tempera-
ture dependent where an increase in contact exposure time or temperature (up to
37◦C) will result in a stronger adhesion or accelerate the stabilisation event (Mc-
Clay et al., 1981). Temperature also influences the fluidity of the cell membrane. A
decrease in temperature leads to a decrease in membrane fluidity (Los & Murata,
2004), which results in a corresponding decrease in susceptibility to shear damage in
the cell (Ramirez & Mutharasan, 1990). Cell damage can also occur during bubble
disengagement at the bulk liquid-gas interface. Cells in contact with the collapsing
thin film of a disengaging bubble are exposed to sufficiently high energy dissipation
rates that can cause cell damage (Chisti, 2000; Garcia-Briones & Chalmers, 1994).
Cell damage resulting in cell loss during centrifugation is not desirable, and has
the effect of lowering the unit operation’s cell recovery efficiency and consequently
overall process efficency. In order to circumvent cell loss that might arise during
89
3.5 Discussion
centrifugation, a set of desirable centrifugation conditions is sought. In this study,
data representing cell losses that arise during centrifugation (Fig. 3.4) is scattered
and contains many variations making data analysis difficult. However, some sense
was made out of the data by applying a rule based scoring system or by searching
for trends in the data by inspection. The conclusions drawn from analysing the
results in such a manner suggest: (1) centrifugation at 21◦C gives rise to lower cell
losses; and (2) extended centrifugation time is the dominant variable with respect
to cell loss, and this is followed by temperature and centrifugal force (see Section
3.3.1). Although useful as process design and operational heuristics, these qualita-
tive conclusions are not very helpful as they are unable to provide a definitive range
of practical centrifuge operating conditions. An alternative method was explored to
analyse the cell loss data to provide a quantitative answer.
The alternative method is based on a statistical consideration of all the data
points examined. p-values generated from a two-tailed Student’s t-test for each data
point representing the probability of cell loss that might arise during centrifugation
was plotted against centrifugation force and centrifugation time for all three process
temperatures investigated (Fig. 3.13). Note that in each plot, the p-values are
in logarithmic form to show clearly the spread of the data and to facilitate the
fitting of the surface to all the data points. The fitted curved surface to the data
points for each process temperature investigated (4, 21 and 37◦C, Panels A, B and
C respectively in Fig. 3.13) depicts the probability response surface for cell loss
during centrifugation. The plane in each panel of the figure represents the 95% level
of confidence (z = log(0.05) = −1.3) at which cell loss does not occur. Centrifuge
operating conditions that lie on this plane and under the fitted probability response
surface represents the set of operation conditions that will incur no cell loss during
centrifugation. Visualising the data in this manner provides a high level of confidence
and clarity in a simple-to-interpret quantitative graphical format when trying to
determine suitable centrifuge operating conditions that results in no cell loss.
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Unlike cell damage resulting in cell loss, cell damage resulting in the loss of cell
viability had a clearer and more well defined correlation to centrifuge operating
conditions. The results in Figure 3.5 suggest that low temperatures preserve the
cell quality irrespective of centrifugation time and centrifugal force. However, as
process temperature is raised, cell quality decreases progressively as centrifugation
time and centrifugal force increases. We propose a cell damage model in which the
degree and mode of cell damage incurred during pellet resuspension is specified by
the processing (centrifugation) conditions. The model is intended to reconcile cell
damage data resulting in loss of cell viability and cell loss from the experiments
(Fig. 3.4 & 3.13) and is deconstructed sequentially into the following four levels of
detail as listed below:
1. Weak cells which are highly susceptible to destructive cell damage are elimi-
nated first resulting in cell loss (Fig. 3.4).
2. For the remaining cells, i.e. those not eliminated by destructive cell damage,
cell damage resulting in loss of cell viability occurs (Fig. 3.5). The changes in
cell viability appear to be a function of centrifugation conditions; increasing
changes in cell viability are incurred as centrifugation force, time and temper-
ature are increased.
3. Cell damage resulting in loss of cell viability is minimised at low process tem-
peratures due to the absence of the strong stabilised cell-to-cell adhesions, thus
allowing for easy dispersal of the pellet within the shear field generated. Also
at low temperatures, cell membranes were less susceptible to shear damage
due to a decrease in cell membrane fluidity.
4. Cell damage resulting in loss of cell viability increases with increasing centrifu-
gation time, centrifugal force and process temperature. Increasing centrifuga-
tion time allows the initial contact adhesion to become more established. It
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is hypothesised that increasing temperature accelerates the rate of cell-to-cell
contact stabilisation as this is metabolically driven. When a shear environ-
ment is generated to disperse the cell pellet, the cell pellet/aggregates persist
longer due to stronger cell-to-cell adhesions and thus are exposed to the larger
and more energetic eddies and elongation flow. Cell membranes at a high
temperature are also more susceptible to shear damage.
As visible bubbles were not generated during the resuspension procedure, cell dam-
age due to bubble disengagement was not considered within the proposed model.
However, its effects cannot be rule out as bubbles invisible to the human eye may
have formed during the resuspension procedure.
From the rule based analysis of Figure 3.4, there was weak evidence to suggest
centrifugal processing cells at 21◦C was better for cell conservation than at 4◦C
and 37◦C. With this interpretation in mind, and from what is known about cellular
responses to temperature variations, it is interesting to compare the likely cause
of cell damage observed. As previously mentioned, cell damage occurs when cell
membrane tension exceeds that of the cell bursting membrane tension. At 4◦C,
homeostatic activity within the cell is interrupted which results in uncontrollable
cell swelling (Boutilier, 2001; Plesnila et al., 2000). The cell swelling due to ion
(K+, Na+, Ca2+ and Mg2+) imbalance across the membrane (Hochachka, 1986)
raises the cell membrane tension. At 37◦C, cell membrane fluidity increases when
compared to lower temperatures. The increase in membrane fluidity makes it more
susceptible to membrane deformations that can also raise the cell membrane tension.
An overall increase in cell membrane tension requires a lower energy input from the
surrounding shear environment to exceed its bursting membrane tension. At 21◦C,
it appears a balance is struck between homeostatic activity, membrane fluidity and
cell membrane tension that leads to cell damage.
Throughout the investigation, we noticed that cell pellets became more tightly
packed as centrifugal force, centrifugation time and process temperature were pro-
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gressively increased. The tight packing structure of the cell pellet is likely to be
due to the increasing amounts of hydrostatic pressure exerted on the collected cells
as centrifugal force is increased. The calculated range of hydrostatic pressure ex-
perienced by the cell pellet was 1.5—6.8 atmospheres (Hydrostatic head pressure
calculated using P = ρgh. 1 atm = 101.3 kN m−2) and this corresponds to 200—
3,000 g of centrifugal force. It seems unlikely that the range of hydrostatic pressures
encountered during centrifugation results in cell damage (Fig. 3.6). The range of
hydrostatic pressures encountered during centrifugation are also unlikely to disrupt
cytoskeletal organisation; the cytoskeleton plays a central role in maintaining cell
shape/structure, cellular division and intracellular transport. For cytoskeletal dis-
ruption to occur, hydrostatic pressures in the range of hundreds of atmospheres
(200—700 atmospheres) have to be applied (Crenshaw et al., 1996; Salmon et al.,
1976).
The concept of Windows of Operation has been applied to various scenarios
in bioprocessing to help optimise and understand bioprocess design and operation.
This study demonstrates for the first time, a developed methodology involving its
use to describe a range of possible operating conditions for the centrifugal recovery
of ES for a regenerative medicine bioprocess. The strength of the concept of a
Window of Operation lies in the ability to organise and present multivarate complex
information into a simple graphical visualisation to aid in bioprocess design decisions.
For instance, from the results in Figure 3.4 and Figure 3.5 it would be difficult
to determine a set of optimal centrifugation conditions that is able to satisfy a
specified bioprocess design requirement, and assess its robustness to changes within
the system. A Window of Operation for centrifugal recovery of mES cells was
generated by predicting centrifuge performance with regards to clarification, cell
damage and process temperature, and combined with a minimum acceptable level of
centrifuge performance, a simple graphical area is defined. Figure 3.12 illustrates the
sensitivity of the available centrifuge operating conditions to a designer by varying
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processing temperature subject to the particular operating limits applied.
The work accomplished in this chapter has examined the physical impact of
centrifugation on mES cells by monitoring the degree of cell damage incurred. Mon-
itoring cell damage however, dose not provide any information to the changes in the
identity (e.g. biological characteristics) of the cell that might have occurred during
centrifugation. The following chapter will examine the impact of centrifugation on
biological characteristics of the mES cell.
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Chapter 4
Results and Discussion:
Impact of Centrifugation on the
phenotype of mES Cells
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4.1 Introduction
Two major sets of results are reported in this chapter. These results relate to the
study of the impact of centrifugation during bioprocessing on the phenotype of the
mES cells. The first set relates to the study of undifferentiated expansion of mES
cells after exposure to a range of centrifugal forces (see Section 4.2). The second
is concerned with the formation of embryoid bodies (EBs) and the differentiation
potential of EBs formed from mES cells exposed to different levels of centrifugal
force (see Section 4.3).
4.2 Undifferentiated expansion of mES cells
In this section, the impact of centrifugation on mES cell proliferation and pluripo-
tency were determined. Following exposure to different levels of centrifugal force,
pelleted cells were resuspended (see Section 2.3.2.2 for resuspension procedure) and
plated onto pre–gelatinised plates at a density of 10,000 viable cells cm−2. Cells were
allowed to proliferate in media containing leukemia inhibitory factor (LIF) for two
days before being analysed. LIF plays a central role in maintaining pluripotency in
mES cells (Boeuf et al., 1997).
4.2.1 Viable cell concentration
The viable cell concentration of mES cell samples taken after centrifugation and
compared with a non-centrifuged control is shown in Figure 4.1 (NB: Fig 4.1 re-
ports total viable cell concentration alongside GFP expression data. Viable cell
concentration data is discussed in this section and GFP expression data is discussed
in Section 4.2.2). The data indicates a reduction in viable cell concentration as
centrifugal force is increased beyond 500 g. The viable cell concentration for the
non-centrifuged control was measured at 13.5 × 104 viable cells cm−2. No signifi-
cant difference (p = 0.499) in viable cell concentration was observed between cells
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measured for the control and after exposure to 500 g of centrifugal force and cell re-
suspension (12.9×104 viable cells cm−2). A decrease in viable cell concentration was
observed as centrifugal force was increased beyond 500 g. When compared to the
control sample (two-tailed Student’s t test, 10% confidence level), mES cells exposed
to 1,000, 2,000 and 3,000 g of centrifugal force recorded a 16% (p = 0.012), 17%
(p = 0.072) and 27% (p = 0.003) decrease in viable cell concentration respectively.
The viable cell concentration analysis suggests that proliferation would be inhib-
ited when attempting to culture mES cells exposed to centrifugal forces 1,000 g or
greater.
4.2.2 Oct4 -GFP expression
The transcription factor Oct4 is inextricably linked to the fate of a cell, and Oct4
gene expression is required to maintain stem cell pluripotency and sustain self-
renewal (Niwa et al., 2000). As a result, Oct4 expression is widely used by investi-
gators as a defining endogenous marker of stem cell pluripotency. The Oct4 -GFP
mES cell line used in this study expresses green fluorescent protein (GFP) under the
regulatory control of the Oct4 gene. As a consequence, GFP expression may be used
as a direct measure of stem cell pluripotency. Cells not expressing GFP are classified
as differentiated mES cells. The impact of centrifugation on mES pluripotency was
determined by evaluating the abundance of GFP in the viable cells of each treated
sample and comparing it to an equivalent non-centrifuged control (Fig 4.1). Three
sub-populations of viable cells were identified as: GFP−, high (i.e. normal) GFP+
and low (i.e. significantly reduced) GFP+ expression.
The percentage population of spontaneously differentiated background cells (i.e.
GFP− cells) was similar in the control sample and all centrifuged samples, averaging
∼ 6%. This value is in agreement with the <8% of spontaneously differentiated back-
ground cells observed in undifferentiated expansion culture of mES cells (Veraitch
et al., 2008). Because the percentage population of GFP− cells remains consistent
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as centrifugal force is progressively increased, GFP− results suggest that centrifugal
force has no impact on the remaining GFP+ pluripotent mES cells.
However, on closer inspection of GFP+ cells, changes in high and low GFP+
cell populations were recorded. The analysis of shifts in high and low GFP+ expres-
sion is described in Section 2.2.3. mES cell population shifts from high GFP+ to low
GFP+ cells indicates a loss of pluripotency in mES cells, i.e. cells are differentiating.
The GFP+ expression data in Figure 4.1 indicates that mES cells progressively lose
pluripotency up to 2,000 g of centrifugal force exposure. These shifts are thought
to be caused by the physical stresses associated with the centrifugal force and sub-
sequent resuspension of the collected cell pellet. Physical stresses and cell stress
responses have been reported to induce differentiation in ES cells (Lin et al., 2005;
Maimets et al., 2008; Shimizu et al., 2008; Yamamoto et al., 2005). When exposed
to 3,000 g, mES cell pluripotency does not seem to be affected; it is hypothesised
that at this exposure level, the hydrodynamic shear damage to the cells associated
with pellet resuspension dominates over stressed induced differentiation and selects
against less pluripotent cells, resulting in a high proportion of high GFP+ cells af-
ter two days of culture. The percentage yield of high GFP+ in the 3,000 g sample
(53%) was not significantly different from the percentage yield of high GFP+ in the
control sample (48%). The percentage yield of GFP (YGFP ) expressing cells is given
in Equation (2.1).
The shifts in yield of high GFP+ expression suggests that mES cell pluripotency
can be influenced centrifugation.
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Figure 4.1: Effect of centrifugal force on mES cells during undifferentiated expan-
sion. Cells were exposed to a range of centrifugal forces for 3 minutes at 21◦C the
resuspended cells were subsequently expanded in culture. Cell concentration and
Oct4 -GFP expression was determined after two days of culture in complete media.
Results are mean ± 2SE for 3 independent wells for each centrifugation condition
studied.
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4.2.3 Gene expression analysis of mES cell pluripotency
Oct4, Nanog, Rex1 and Utf1 are genes expressed in undifferentiated mES cells and
therefore are used as markers of pluripotency (Ben-Shushan et al., 1998; Mitsui
et al., 2003; Niwa et al., 2000; Okuda et al., 1998; Yates & Chambers, 2005). To
determine if varying levels of centrifugal force applied during centrifugation affected
the pluripotency of mES cells, gene expression for Oct4, Nanog and Rex1 was anal-
ysed using RT-PCR (Fig. 4.2). Neither Oct4 nor Nanog nor Rex1 expression were
affected by the different centrifugal force exposures as their expression levels were
similar to the control sample. The results indicate that mES cells were not affected
by centrifugation and were able to maintain their pluripotentcy. Gene expression
for Oct4, Nanog and Utf1 gene expression was subsequently quantified using qPCR.
Figure 4.3 shows the relative change in gene expression levels of Oct4, Nanog
and Utf1 of mES cells exposed to 500, 1,000, 2,000 and 3,000 g of centrifugal force
relative to the non-centrifuged control sample. No significant changes in the lev-
els of Oct4 and Nanog expression were detected between control and centrifuged
samples. Similarly, differences in expression levels of Utf1 in centrifuged samples
were not significant when compared to the control except for the sample exposed to
centrifugation at 500 g (0.4 fold change; p = 0.034).
Although Utf1 is used as a marker for pluripotency, its exact role within the
regulatory network that controls self-renewal and differentiation in ES cells is un-
clear. So far, Utf1 has been identified to be a stable chromatin-associated protein
involved in the initiation of differentiation, and has been implicated in maintaining
a specific epigenetic profile in ES cells (van den Boom et al., 2007). It has also
been reported to participate in cell proliferation by promoting cell cycle progression
in early embryos (Nishimoto et al., 2005). A possible explanation in the variation
in expression of Utf1 observed at 500 g may lie in its regulation. As Utf1 is tran-
scriptionally activated by the synergistic action of Oct4 and Sox2 (Nishimoto et al.,
1999), it is thought that the tight regulation of Utf1 makes it highly sensitive to the
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minute changes in levels of Oct4 and Sox2 present. Also, we have in the research
group unpublished data to suggest that large variations in Utf1 expression levels
across mES clones from the same cell line with similar Oct4 expression levels is
possible. Further examination into the use of Utf1 as a definitive marker for stem
cell pluripotency is required to confirm the variation observed in Figure 4.3 C.
The gene expression analysis of Oct4, Nanog and Rex1 suggests that centrifuga-
tion does no affect mES cell pluripotency.
The discrepancy between the findings drawn from the Oct4 -GFP analysis and
pluripotency marker analysis is connected with the resolution of the assay used.
Oct4 -GFP analysis resolves pluripotency at the protein level whereas qPCR resolves
pluripotecy at the gene expression level and results from either assay technique are
valid. Protein translation and folding rates are presumed not to be a limiting factor
in the analysis as they are in the order of seconds to minutes and milliseconds
respectively. Crucial to studying the impact of centrifugation is the ability to detect
subtle changes in pluripotency with respect to changes in centrifugation. Analysis
of Oct4 at the protein level based on relative GFP fluorescence using flow cytometry
occurs on a per cell basis and allows for a population of mES cells to be distinguished
between low or high levels of Oct4. In contrast, Oct4 analysis at the transcription
level is unable to afford this distinction as cells are assayed as an entire population.
This example illustrates the importance of an understanding of the system and
selecting an appropriate analytical method to quantify it. Alternatively, the effects
of centrifugation on mES cell pluripotency can be evaluated by making chimeras.
(Chimeras are produced from mixing cells from two different organisms, in this case
centrifuged mES cells can be injected into blastocysts and implanted into a host and
allowed to develop). While chimera formation is laborious and beyond the scope of
this thesis, it is possible that the variations seen in pluripotency of centrifuged mES
cells are of no consequence in vivo, as other yet to be identified extrinsic biological
factors will come into play.
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Figure 4.2: RT-PCR analysis of mES cells exposed to different levels of centrifugal
force. Following centrifugation, cells were allowed to proliferate in culture for two
days before being analysed for the presence of the pluripotent markers Oct4, Nanog
and Rex1 ; with β-actin as the internal control. All samples were positive for the
pluripotent markers. Lanes 1, 2, 3 4 and 5 correspond to the control sample and
samples centrifuged at 500, 1,000, 2,000 and 3,000 g.
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Figure 4.3: Gene expression analysis of mES cells exposed to different levels of
centrifugal force. Following centrifugation and resuspension, cells were allowed to
proliferate for two days and transcription levels of pluripotency markers Oct4 (Panel
A), Nanog (Panel B) and Utf1 (Panel C) were determined using qPCR. Expression
levels were standardised to β-actin and normalised to the uncentrifuged control
sample. Results are mean ± SE of two independent samples analysed in triplicate.
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4.3 Embryoid body expansion and differentiation
In this section, mES cells were examined for their ability to form and propagate as
EBs (3-D spherical cell aggregates), and their ability to retain pluripotent differen-
tiation capacity after being exposed to centrifugal force. After exposure to different
levels of centrifugal force and subsequent resuspension, mES cells were plated onto
non-tissue culture treated petri dishes. Plated cells were allowed to form EBs under
static suspension culture conditions in LIF-free complete medium and propagated
over 8 days. Culture medium exchange was performed every two days, during which
EB samples were collected. Collected EBs were trypsinised and assayed for cell
number, cell viability and used for quantitative PCR analysis.
4.3.1 Growth characteristics
Cell growth curves for mES cells exposed to each centrifugation condition (including
the non-centrifuge control) was established by plotting cell viability and viable cell
density against time (Fig. 4.4, Panels A & B respectively). Viable cell density data
for each centrifugation condition was normalised to a starting cell density of 5× 105
viable cells mL−1 to provide a means of comparing cell growth characteristics over
the course of the experiment.
Analysis of the non-centrifuged control culture (0 g) revealed that mES cells
were capable of being maintained in static culture conditions for up to 8 days whilst
maintaining a high overall cell viability (> 80%). The non-centrifuged control cul-
ture exhibited a 3-phase growth pattern: (1) a cell death phase from days 0 to 2,
where 68% of available viable cells on inoculation were lost by day 2. This decline in
viable cell number is likely to be attributed to a combination of cell death brought
on by the failure of the attachment dependent mES cells to spontaneously aggregate
after inoculation (Koyanagi-Katsuta et al., 2000), and cell loss during the gravity
settling step of the media exchange procedure; (2) a growth phase from days 2 to
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4, where the surviving viable cells (likely to be nascent EBs at this stage) grew to a
high viable cell density on day 4 representing a 4.8 fold increase in viable cells from
day 2; and (3) a maintenance phase from days 4 to 8 as indicated by the high % cell
viability throughout; and where viable cell numbers dipped slightly and remained
constant.
The growth characteristics of cultures inoculated from mES cells exposed to
different levels of centrifugal force (500, 1,000, 2,000 and 3,000 g) revealed a similar
cell death phase (days 0 to 2) and growth phase (days 2 to 4) pattern to the non-
centrifuged control culture. On closer inspection of the viable cell data we note that
more cells were lost in the cell death phase in centrifuged cultures when compared
to the non-centrifuged control. The remaining cells in centrifuged cultures at the
end of the growth phase recovered to viable cell densities similar or greater than the
non-centrifuged control. For all centrifuged cultures, cell loss during the death phase
averaged 83% on inoculation and the gain in cells during the growth phase averaged
12.3 fold. Also, cell viabilites recorded over these two phases (on days 2 and 4)
indicate a decreasing trend in cell viability as centrifugal force is is progressively
increased at the end of the death phase, and a recovery to non-centrifuged control
levels at the end of the exponential growth phase.
When viewed together, viable cell density and cell viability data give the impres-
sion that centrifuged cells are more prolific than the non-centrifuged control cells.
The calculated normalised specific growth rates (µ) and normalised doubling times
(td) of all centrifugation conditions examined also support this observation. From
Table 4.1 which summarises these calculated values, non-centrifuge control cultures
(0 g) recorded the lowest specific growth rate (0.033 ± 0.007 hour−1) and the highest
doubling time (21.2 ± 4.5 hours) in comparison to centrifuged cultures. Based on
the differences observed in viable cell densities, specific growth rates and doubling
times between centrifuged and non-centrifuged control cells, it would be reasonable
to suggest that: (1) all starting cell samples comprise of a mixture of cells with vary-
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ing proliferation capacities, and (2) on centrifugation and subsequent resuspension,
the less prolific cells are eliminated thus giving rise to a population of more prolific
cells that serve as the initial inoculum (See section 3.5 on page 88 for description of
presumed cell loss action during cell pellet resuspension).
Viable cell densities recorded on days 6 and 8 for centrifuged cells are indica-
tive of a second death phase, and is in contrast to the maintenance phase recorded
for the non-centrifuge control culture over the same period. Unlike the first death
phase observed in all centrifugation conditions, the second death phase is not due
to an inability of the attachment dependent mES cells to aggregate because phase
contrast images indicate the presence of EBs (Fig. 4.5). The discrepancy between
culture phases of centrifuged cells and non-centrifuged control cultures over this pe-
riod maybe explained in terms of nutrient and oxygen transport limitations within
the EB. In particular, within EBs of the centrifuged mES cells that are composed
of highly prolific cells. The high consumption rate associated with rapidly prolifer-
ating cells coupled with a nutrient and oxygen transport limitation may account for
the second death phased observed in centrifuged cells. The influence of transport
limitation on viable cell yield from EB cultures is verified in a study by Carpenedo
et al. (2007). The study reports a reduction in apoptotic core and dead cell clus-
ter formation within EBs cultured in continuous flow conditions when compared to
static culture conditions.
Because of the scatter in the data, it is difficult to comment precisely at this
juncture if progressively increasing exposure to centrifugal force and the associated
resuspension procedure results in a corresponding increase in cell proliferation and
viable cell loss. However, the evidence given from the cell viability recorded on day
2 seems to suggest so (see Appendix A for additional information) . The source of
scatter is likely to be due to the inherent variability encountered during the sampling
and assay of EBs. To refine the observations made on the date presented in Figure
4.4, additional studies involving a higher sampling frequency (2—3 samples day−1)
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and independent replicate runs (≥3) would be required.
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Figure 4.4: Growth curves of static EB culture inoculated with mES cells exposed
to different levels of centrifugal force. Cell viability (Panel A) and viable cell density
(Panel B) were determined over the course of 8 days with culture medium exchanged
every two days. Viable cell densites for each centrifugation condition was normalised
to a starting cell density of 5×105 viable cells mL−1. Results are means of triplicate
samples for a single experimental run. Error bars have been omitted for clarity.
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Table 4.1: Normalised specific growth rates (µ) and doubling times (td) for static EB
cultures inoculated with mES cells exposed to different levels of centrifugal force. µ
and td were calculated using Equations (2.20) and (2.21) and data from the growth
phase (days 2 to 4) of each batch culture. Results are means ± 2SE of triplicate
samples from a single experimental run. Arguably, it is not possible to accurately
calculate specific growth rates and doubling times from two data points in a growth
curve. However, the the calculated values presented in this table given an indication
as to how the EB cultures are performing and the values are comparable to literature
values Cormier et al. (2006).
Condition Specific growth rate (hour−1) Doubling time (hour)
0 g 0.033 ± 0.007 21.2 ± 4.5
500 g 0.057 ± 0.007 12.3 ± 1.5
1,000 g 0.045 ± 0.015 15.4 ± 5.2
2,000 g 0.060 ± 0.032 11.5 ± 6.0
3,000 g 0.041 ± 0.008 17.0 ± 3.2
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4.3.2 EB formation
To assess the effect of centrifugal force and subsequent resuspension on mES cells
used for EB formation, mES cells exposed to different levels of centrifugal force to-
gether with a non-centrifuged control were observed using phase contrast microscopy
(Fig. 4.5). Phase contrast images (4× magnification) were captured prior to culture
medium exchange. EB diameter (Table 4.2) and EB concentration (Fig. 4.6) were
determined from the phase contrast images using ImageJ image analysis software
(v.138x). A minimum of 100 EBs were analysed per sample. The images captured
on days 4 and 8 of all centrifugation conditions depict features characteristic of static
suspension EB culture. EBs appear to have a wide range of sizes, and are either
irregular or roughly circular in shape. These characteristics stem from the variation
in the number of cells incorporated into each EB during cell aggregation (Kurosawa,
2007). Based on the phase contrast images EBs formed appear to be non-cyctic in
morphology due to the dark/opaque centers, however, this can only be confirmed
though histological examination of EB samples.
By day 4 (Fig. 4.5 A–E), centrifuged and non-centrifuged control mES cells
formed medium sized EBs, averaging 151 µm in diameter. A higher proportion of
smaller EBs were apparent in the culture centrifuged at 2,000 g (Fig. 4.5D) when
compared to the non-centrifuged control and centrifuged cultures at 500, 1,000 and
3,000 g. This higher proportion of smaller EBs within the culture accounts for the
significantly (p = 0.041) smaller average EB diameter (141 µm; Table 4.2), and an
∼2 fold higher EB concentration (Fig. 4.6) when compared to the non-centrifuged
control. A combination of slow spontaneous EB aggregation and poor EB handling
resulting in fragmentation during the previous medium exchange is presumed to be
the cause of the higher proportion of smaller EBs visible in the 2,000 g culture.
By day 8 (Fig. 4.5 F–J), EBs from centrifuged and non-centrifuged control
cultures grew to an average diameter of 190 µm, representing an average gain of 39
± 9 µm on day 4 EB diameters for all centrifugation conditions investigated. The
111
4.3 Embryoid body expansion and differentiation
gain in EB diameter can be attributed to both cell growth and EB agglomeration.
The EB diameters of EBs formed from mES cells exposed to centrifugation were
not significantly different from the non-centrifuge control (Table 4.2). However, an
∼2 fold greater concentration of EBs in the culture centrifuged at 500 g was visible
when compared to the non-centrifuge control (Fig. 4.6); a similar explanation to
above is used account for the high EB cell concentration observed. Phase contrast
images of this centrifugation condition (Fig. 4.5G) suggest that the proportion of
smaller EBs present are low; and as a consequence of a low incidence of smaller
EBs, the calculated overall average EB diameter is not significantly altered. For all
intents and purposes, despite the higher proportions of EBs observed in Fig. 4.5 D
& G, they about the same as their respective control.
The image analysis indicates that mES cells exposed to centrifugal forces up to
3,000 g are capable of forming EBs without affecting the average EB diameter.
While the term embryoid body (EB) has been used to describe ES cell assemblies,
it should not be confused from the term ES cell aggregates that is sometimes found
in literature. In general, EBs are assembled from ES cells that are allowed to
spontaneously aggregate and spontaneously differentiate under non-differentiating
medium conditions (e.g. mES EB formation using LIF free culture medium). This
spontaneous differentiation is driven by the cell-to-cell interactions within the EB
that recapitulates the early developmental changes observed in embryogenesis. As
a result of theses interactions, ES cells within the EB begin to differentiate and give
rise to progenitor cells that make up the three primary germ layers. In contrast,
ES cell aggregates are ES cell assemblies that consist of progenitor cells committed
towards a particular cell lineage. The lineage committed progenitor cells are formed
via directed differentiation of ES cells (or EBs), and is typically achieved by adding
specific growth factors to the culture medium that induce cells to differentiate along
a particular pathway (Dontu et al., 2003; Okada et al., 2004; Youn et al., 2005).
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Table 4.2: Average EB size after 4 and 8 days of static culture. mES cells used to
form embryoid bodies were exposed to a range of centrifugal forces. EB diameters
were measured using ImageJ image analysis software (v1.38x). Average EB diame-
ters of centrifuged cultures were compared to the non-centrifuge control culture (0
g). Results reported are mean ± 2SE determined from a minimum of 100 EBs.
Day 4 Day 8
Condition Diameter (µm) p-value Diameter (µm) p-value
0 g 155 ± 10 – 194 ± 23 –
500 g 160 ± 16 0.608 202 ± 21 0.647
1,000 g 148 ± 11 0.365 169 ± 19 0.098
2,000 g 141 ± 8 0.041 188 ± 21 0.705
3,000 g 151 ± 11 0.628 194 ± 23 0.964
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Figure 4.6: EB concentrations determined after 4 and 8 days of static culture. mES
cells used to form EBs were exposed to a range of centrifugal force. Results reported
are mean ± 2SE.
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4.3.3 EB gene expression analysis
To demonstrate that EBs formed from mES cells exposed to centrifugation were
capable of differentiation, their differentiation status was evaluated after 8 days
of static suspension EB culture. The pluripotent differentiation capacity of EBs
are typically assessed on their ability to give rise to cells that make up the three
primary germ layers, namely the endoderm, mesoderm and ectoderm layers. Endo-
derm cells form the outer layer of the EB which surrounds a central core composed of
mesoderm and ectoderm cells. Gene expression of the germ layer markers SRY-box
containing gene 17 (Sox17 ), Brachyury (T ) and β3-tubulin (Tubb3 ) were assessed
quantitatively using PCR (Fig. 4.7), and are early developmental markers of en-
doderm, mesoderm and neuroectoderm respectively (Nakanishi et al., 2007). Sox17
is a transcription factor that participates in extraembryonic endoderm specification
(Shimoda et al., 2007), T expression occurs during early stage mesoderm devel-
opment (Wilkinson et al., 1990), and βIII-tubulin is a neuron specific microtuble
isoform that is synthesised in postmitotic neuroblasts (Lee et al., 1990).
Sox17, T and βIII-tubulin were expressed in all centrifuged and non-centrifuged
control cultures thereby confirming in all cases the development of the three primary
germ layers that typify EB differentiation in vitro. This result was anticipated as it
is generally assumed that EBs are capable of recapitulating the early developmental
changes in embryogenesis where the markers for endoderm, mesoderm and ectoderm
layers are invariably expressed (Choi et al., 2005; Doetschman et al., 1985). Higher
levels of Sox17 were detected in EBs formed from mES cells exposed to 2,000 and
3,000 g when compared to EBs formed from cells exposed to 500 and 1,000 g, and
the non-centrifuged control. T expression was elevated in EBs formed from mES
cells exposed to 3,000 g, and all other conditions showed insignificantly higher ex-
pression levels when compared to the non-centrifuged control. Tubb3 expression
levels were similar under all centrifugation conditions to the non-centrifuge control.
The increased expression of endoderm and mesoderm expression at higher levels of
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centrifugation suggest that differentiation is induced sooner. Because the enveloping
endoderm provides the cell signals required for differentiation (Maye et al., 2000),
it is possible that the elevated levels of T expression is a consequence of the high
levels of Sox17. Signals from the endoderm are also responsible for creating cavi-
ties within EBs, i.e. formation of cystic EBs by inducing apoptosis of cells at the
core (Coucouvanis & Martin, 1995), thus also possibly contributing to the second cell
death phase observed in centrifuged EB cultures (Fig. 4.4). The comparable expres-
sion of Tubb3 at all centrifugation conditions examined indicates that centrifugation
did not inhibit or delay differentiation into the neuroectoderm.
The gene expression analysis shows that in general, mES cells exposed to various
centrifugal forces prior to EB culture do not lose their pluripotent potential to
differentiate. Although the data suggests that higher levels of centrifugal force and
the subsequent effects of resuspension of the cells used to prepare the EBs induce
early differentiation of endoderm and mesoderm, further studies are required to
verify these results. There is a possibility that early induction of differentiation
is related to the selection of more prolific cells by the centrifugation procedure.
These additional studies maybe conducted in a monolayer differentiation culture
system to reduce the complex 3D cell-to-cell interaction and signaling environment
associated with an EB and better study the effects of centrifugation. A monolayer
culture system also allows for better culture synchronisation and makes cells more
amendable to manipulation with factors (West et al., 2006).
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Figure 4.7: Gene expression analysis of static EB cultures inoculated with mES
cell exposed to different levels of centrifugal force. After 8 days of static culture,
transcript levels of germ layer markers Sox17 (Panel A), T (Panel B) and Tubb3
(Panel C) were determined using qPCR. Expression levels were standardised to
β-actin and normalised to the control sample. Results are mean ± SE of two
independent samples analysed in triplicate
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4.4 Discussion
It is generally acknowledged that pluripotent ES cells in culture are an artifact
of their in vitro conditions because these cells rapidly differentiate in situ during
embryo development (Avery et al., 2006). Like a double edged sword, the plasticity
in the biological properties of ES cells which allows them to differentiate, makes
them susceptible to external bio-physical and biochemical cues. Typical ES cell
expansion and differentiation culture protocols necessitate the use of centrifugation
to effect cell separation from its suspending bulk medium for routine sub-culture
(cell expansion) or subsequent use downstream (cell differentiation). The results
presented in this chapter highlight the sensitivity of mES cells to centrifugation. In
doing so, hopes to identify critical parameters which may become helpful in designing
effective strategies to maintain or exploit ES cell properties, and maximise overall
bioprocess productivity.
From the point of using centrifugation for collecting cells for routine sub-culture
or subsequent downstream use, the results show that the proliferation of undifferen-
tiated and differentiated mES cell populations can be affected by centrifugation. In
addition, exposing mES cells to centrifugation also affects its pluripotency and dif-
ferentiation status. Clearly gaining high yields of mES cells of the desired phenotype
(i.e. undifferentiated or differentiated cells) is linked to centrifugation. Control over
centrifugation conditions has to be exerted to ensure reproducibility and stability
of cultures over multiple sub-cultures or extended periods of culture. The results
strongly suggest that restricting exposure to no more than low levels of centrifugal
force is necessary to safeguard the stability of the desired biological characteristics of
mES cells during sub-culture. Excessive centrifugation is detrimental to the culture
of mES cells.
From the point of using centrifugation to exploit mES cell properties, the re-
sults suggest that by judiciously selecting an appropriate centrifugation speed, mES
cells can be persuaded towards a desired outcome. The outcome though, maybe a
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compromise of overall bioprocess productivity and is probably the more important
operating parameter. Two examples are given here: (1) in the undifferentiated mES
cell expansion study, cells exposed to 3,000 g of centrifugal force exhibited a 27%
decrease in viable cell concentration when compared to the non-centrifuged control.
At the same time no change in pluripotency was exhibited. In a scenario where
large volumes of mES cells have to be processed, operating the centrifuge at 3,000 g
reduces the time required to achieve a desired level of clarification for an equivalent
volume of cells to be processed when compared to lower levels of centrifugal force.
It is possible that while still maintaining a high level of pluripotency, the savings
in centrifugation time outweighs the diminished cell proliferation. Furthermore, the
savings in processing time also decreases the exposure of the sensitive mES cells to
the surrounding ambient conditions that can cause culture variations (e.g. growth
rates, phenotype) (Veraitch et al., 2008); and (2) in the EB expansion and differ-
entiation study, increasing levels of centrifugal force promoted cell proliferation and
a possibility of early induction of endoderm and mesoderm differentiation. Where
high levels of viable cells are desired to maximise overall bioprocess yield, high cell
proliferation rates are beneficial. However, the benefits of an increased proliferation
rate within an EB is curtailed by a probable nutrient transport limitation resulting
in reduced viable cell numbers when compared to the non-centrifuged control. Thus
in order to maximise overall cell numbers a compromise between centrifugal force
and cell proliferation rates has to be established. Alternatively, highly prolific EBs
may be cultured in continuous flow conditions to improve nutrient and gas diffu-
sion that promotes cell viability (Carpenedo et al., 2007). Where endoderm and
mesoderm cells are desired, high centrifugal forces are advantageous. The use of
the bioprocessing environment to direct ES cell differentiation is not new and has
been described by Yamamoto et al. (2005) and Shimizu et al. (2008); however these
efforts have only been confined to culture conditions only.
Undoubtedly, the combined effects of centrifugation and resuspension are able
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to influence yield and the desired biological characteristics of mES cells. The shear
environment generated during resuspension works on two levels to influence mES
cell attributes: (1) it first eliminates cells (e.g. cell damage resulting in loss in cells
or viability) that are susceptible to the shear environment, and (2) it provides the
physical stress cues for the remaining cells to be transduced. Because exposure
to centrifugal force has been shown not to eliminate cells (Fig. 3.6), its influence
on mES cell attributes is assumed to be exclusively mechanical, i.e. it provides
physical stress cues only (The effects of oxygen concentration has been omitted
from this consideration). Although little is known about the specifics of how varying
levels of physical stress are able to modify mES cell pluripotency and differentiation,
it appears that cell cytoskeleton plays a crucial role in the signal transduction of
these mechanical forces (Ingber, 1997; Sadoshima & Izumo, 1997). Additionally, cell
stress responses to the shear environment have to be considered (Lin et al., 2005;
Maimets et al., 2008). Concerning the shear environment and bioprocessing, they
are inextricably linked and together represent major challenges in developing robust
and scalable processes for cell based regenerative medicines (Zoro et al., 2008).
In hindsight, the EB expansion and differentiation study was probably limited
by the chosen experimental method employed. Because of the relatively low culture
volumes involved (∼ 12 mL), it is highly likely that cell and fluid losses were intro-
duced during the medium exchange procedure over the course of the experiment.
In particular, as EBs were allowed to gravity settle out of the spent medium before
being replaced, it is likely that nascent EBs would have been discarded together
with the spent medium (Fig. 4.4, day 2 cell counts: cell loss observed could be
due to a combination of cells spontaneously aggregating to form EBs and nascent
EBs that are unable to settle out of the spent medium). In addition to medium
exchange losses, cell sampling losses due to the extensive handling of the EBs sam-
ples required for cell enumeration have to be taken into account. Despite these
shortcomings, it would not be unreasonable to assume that the errors associated
121
4.4 Discussion
with cell and fluid losses were systemic errors that were propagated evenly across
all centrifuge conditions investigated. Owing to the fact that systemic errors and
cell loss were incurred, the reliability of the results reported (e.g. EB formation and
gene expression analysis data) could possibly been affected.
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Paramount to the successful manufacture of any cell based regenerative medicine on
an industrial scale is a fundamental understanding of the bioprocessing environment
and its impact on cells. Where ES cells are to be utilised as a renewable source
for cell therapy, this understanding has to be extended not only to preventing cell
loss, but also its impact on ES cell expansion and differentiation. It is envisaged
that centrifugation will play a central role in the primary recovery of ES cells in
whole cell bioprocessing as centrifuges are generally easy to operate and scale. It is
recognised that the scale of ES cell bioprocesses is determined by the useful amount
of therapeutic material required for therapy and may fall into the following two scale
categories: (1) 10s of milliliters to liters; and (2) 10s to 100s of liters. The two ES
scale of operations mirror closely the scale of operations encountered in autologous
or allogenic whole cell bioprocessing.
The research in this thesis aims to highlight crucial areas in ES cell bioprocessing
ahead of the industrial need as determined by market demands. A mES cell line
was selected as a mimic for ES cell types that will be used in cell based regenerative
medicines; the work accomplished centers about using milliliter volumes of mES cell
suspensions to demonstrate techniques useful in the characterisation and analysis
of centrifuge performance, and to study the bioprocessing impact of centrifugation
on mES cells. The results from this study hope to serve as a starting point for
investigators who are seeking identify critical centrifugation process variables to
design cell recovery stratagems for both terminally differentiated and hES cells at
various processing scales. At a more strategic level, the work undertaken within this
thesis serves to create and establish an awareness of the bioprocessing challenges
faced within this emerging area of science.
The results indicate that centrifugal force, centrifugation time and process tem-
perature affects the population of mES cells as recovered after pellet resuspension.
Cell damage during centrifugation resulting in loss of cells or cell viability is probably
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not caused directly by direct exposure to centrifugal force, but by the environment
generated during cell pellet resuspension. With the level of cell damage incurred
being determined by centrifugal force, centrifugation time and process temperature.
To minimise cell damage whilst optimising centrifuge performance, a Window of
Operation for centrifugal cell recovery of mES cells was generated by predicting
clarification and cell damage with regards to centrifugation conditions and process
temperature. The resultant Window of Operation points to a requirement to min-
imise the exposure of cells to harsh centrifugation conditions (e.g. high centrifugal
force, centrifugation time and process temperature) to limit cell damage. It is useful
to highlight at this juncture a common minimum centrifugal force and centrifuga-
tion time that minimises cell damage at 4, 21 and 37oC process temperatures; for a
> 99% recovery of cells and a < 1% change in cell viablilty, the centrifuge can be
operated at 5–9 mins × 300–500 g. These centrifugation condtions are similar to
standard laboratory practices used for the recovery of animal cells.
In addition to cell damage, the combined effects of centrifugal force and mechani-
cal stresses stemming from the shear environment generated during the resuspension
procedure seems to affect the biological characteristics of mES cells during expan-
sion and differentiation. The results strongly suggest that restricting exposure to
no more than low levels of centrifugal force is necessary to safeguard the stability
of desired plastic mES cell characteristics. During mES cell expansion, cell prolifer-
ation and cell pluripotency were influenced by increasing levels of centrifugal force
as indicated by viable cell numbers and Oct4 -GFP expression respectively. During
mES cell differentiation, the growth characteristics and differentiation status of EBs
appear to be altered as centrifugal force is progressively increased. Exposure of cells
to increasing levels of centrifugal force did not appear to affect the cell’s ability to
form EBs in static suspension culture.
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The list of exciting research opportunities involving the use of ES cells is vast and
diverse. Currently, the bulk of research in this area relates to the elucidation and
understanding of ES cell biology and is beyond the intent of this thesis. The research
opportunities highlighted below are restricted to the arena of bioprocessing:
• Cell damage with respect to process temperature. From the rule based inter-
pretation of Fig. 3.4, the data suggests that processing cells at 21◦C results
in lower cell losses when compared to processing at higher (37◦C) or lower
(4◦C) temperatures. It was hypothesised that a balance between homeostatic
activity, membrane fluidity and cell membrane tension is struck in order to
minimise cell loss (see Section 3.5 on page 88). Studies examining this hy-
pothesis would provide useful information to facilitate bioprocess design and
bioprocess scheduling decisions. In particular, the use of low process temper-
atures as a stratagem in preserving cells over extended periods (Hunt et al.,
2005). The study may also be further extended to examining the effects of
rewarming injury to cells (Healy et al., 2006; Rauen et al., 2000).
• Scalability. Where biological material under investigation is precious and not
available in large quantities , data generated at the milliliter (or microliter)
scale to predict manufacturing scale process performance is invaluable in terms
of cost savings and then different bioprocess scenarios and variables that can
be investigated. The research undertaken in this thesis centres about the use of
milliliter volumes of mES cell suspension to generate quantitative centrifuga-
tion data in order to facilitate bioprocess design decisions. The research under-
taken can be further extended to cover correlating and validating the milliliter
scale data to predict full scale centrifuge performance. This is achieved by un-
derstanding the properties of the biological properties and how the dominant
flow regime within the industrial scale centrifuge (batch or continuous) affects
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these properties. See review by Titchener-Hooker et al. (2008) on microscale
biochemical engineering analysis.
• Tangential flow filtration (TFF). Studies examining the performance of TFF
for ES cell recovery and how the flow regime during TFF recovery (e.g. pres-
sure, shear, pump damage etc) influence ES cell pluripotency and differentia-
tion potential. The data could be compared against centrifugal recovery data
as centrifugation and TFF are in competition, and maybe used to build a
database or design heuristics that would facilitate the design and development
of future whole ES cell bioprocess. The study may also be further extended by
comparing the process cost-benefit gains associated with each unit operation
when governed by a particular scale of operation.
• Validated holding steps built into any industrial bioprocess allows for process
flexibility in case of contingencies. Lowering process temperatures to no lower
than freezing is also another common stratagem in preserving cells over ex-
tended periods (Hunt et al., 2005). Studies of the impact of time-temperature
exposure to ES cells in holding steps prior to subsequent processing would pro-
vide useful information to facilitate bioprocess design decisions. Additionally,
the effects of rewarming causing injury to cells may also need to be assessed
(Healy et al., 2006; Rauen et al., 2000).
• Hydrodynamic forces encountered during bioprocessing are able to induce a
variety of cell responses (Chisti, 2001) and are present from cell culture, to
pumping and pipe transfer operations and primary recovery. Where the bio-
processing of ES cells are concerned, the microenvironment has been reported
to affect pluripotency or differentiation (Saha et al., 2005; Shimizu et al., 2008;
Yamamoto et al., 2005) — these studies though only relate to culture condi-
tions. Studies related to quantifying ES cell responses (i.e. cell loss, changes
in pluripotency potential or differentiation status) when exposed to a specific
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magnitude of force and flow regime when not in culture will aid in development
of a bioprocessing equipment sector which is able to cater to the specialised
demands of processing ES cells (Mason & Hoare, 2006).
• The epigenetic impact of bioprocessing on ES cells. Epigenetics relates to
the process whereby a substance and/or environment changes gene expres-
sion without a change in DNA sequence. The features and factors that affect
gene expression have been identified and include transcription factors, microR-
NAs, DNA methylation and histone mediated changes in chromatin structure
(Bibikova et al., 2008). Where ES cells are concerned, there is an increasing
body of evidence for an epigenetic basis for pluripotency and differentiation
potential (Atkinson & Armstrong, 2008; Collas et al., 2008; Gan et al., 2007).
However, as the precise epigenetic mechanisms are currently not well under-
stood, it is important to recognise and possibly identify the bioprocess engi-
neering conditions that can significantly influence the epigenome and affect
the safety and efficacy of cells used for therapy.
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Extracted from the EB growth curve data (Fig. 4.4), the information presented
in Table A.1 contains further supporting evidence that centrifugal force influence
EB cell proliferation and cell loss.
Table A.1: Table summarising the percentage (%) drop in cell viability in EBs after
2 days of static suspension culture, and fold change in viable cells in EBs from day
2 to day 4 (increase), and day 4 to day 6 (decrease). EBs were formed from mES
cells exposed to a range of centrifugal force.
Fold change in viable cell from:
Condition % drop in cell viability Day 2 to Day 4 Day 4 to Day 6
0 g 10.9 4.79 0.86
500 g 16.2 15.11 0.72
1,000 g 3.9 8.69 0.54
2,000 g 36.9 18.17 0.47
3,000 g 49.9 7.09 0.24
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